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The aim of this dissertation was to begin to understand how biopolymer interactions 
affect mechanical and structural properties of biomaterials, and how those properties 
affect stem cell behavior. Polysaccharide, oligopeptide and oligopeptide-
polysaccharide composite materials were made and then characterized using a range 
of techniques. It was found that chondroitin addition to chitosan-alginate networks 
improved both tensile and compressive strength. Increasing polysaccharide 
concentration also improved mechanical properties. Also, polysaccharide 
incorporation into peptide hydrogels increased biomaterial resistance to strain break. 
Structural analysis supported mechanical data, showing that incorporation of the 
peptides dramatically changed the morphology of the polysaccharide networks. 
Biopolymer chirality was also explored in this work. By incorporating 
polysaccharides and oligosaccharides into both L- and D-forms of peptide hydrogels, 
we observed differences in mechanical properties not seen in L- and D-oligopeptide 
  
hydrogels alone. Greater interactions between L-oligopeptides and D-saccharides lead 
to stronger materials with distinctively different structural characteristics from 
hydrogels made from D-oligopeptides and D-saccharides. This phenomenon, known 
as chiral selectivity, has previously only been seen at the molecular level. Here, we 
showed that chiral selectivity is another unique property of biopolymers that can be 
exploited to tune mechanical and structural properties of materials. Chiral selectivity 
was also observed in terms of stem cell behavior in this work. However another 
property, hydrogel charge, was used to diminish the effects of chiral selectivity in 
order to enhance the biocompatibility of D-oligopeptide hydrogels. It was found that 
negative charges significantly improved human mesenchymal stem cell attachment 
and proliferation in D-oligopeptide gels but had little effect on their interactions with 
L-oligopeptide gels.  These results suggest that it is possible to use charge and other 
properties of biopolymers to engineer biomaterials whose chirality is distinct from 
that of natural biomaterials but whose performance is close to that of natural 
biomaterials. These oligopeptide-based biomaterials also offer new tools to 
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Chapter 1: Introduction 
1.1 Biopolymers in Biomaterials Research 
The new emphasis in the field of tissue engineering has been on the design and 
engineering of degradable materials that aid in the regeneration of tissues (1). One of 
the most prevalent approaches involves employing biopolymer-based biomaterials as 
a support system for the delivery of cells and/or growth factors to damaged tissues 
(2,3). This undertaking requires that the biomaterial provides sufficient mechanical 
support during tissue rebuilding.  
In addition to providing mechanical support, it is important for the biomaterial to 
support and sustain an environment that enables appropriate cellular growth, adhesion 
and differentiation. An appropriate cell environment is the key to eliciting new tissue 
development (4). As supports for cell growth, synthetic biodegradable polymers have 
been widely used (5). However, in order to stimulate or modulate new tissue 
development, synthetic materials must be supplemented with bioactive molecules like 
BMP (bone morphogenetic protein) and FGF-2 (fibroblast growth factor 2) to name a 
few (6). In contrast, naturally derived polymers have a built-in ability to stimulate 
tissue growth. Several of these biopolymers (e.g. chondroitin sulfate, heparan sulfate, 
collagen, etc.) are components of or mimic the extracellular matrix (ECM), thus they 
ordinarily interact with cells. For example, since the ECM is important in regulating 
elements of cell adhesion, division and differentiation, biopolymers are a good 




Compared with synthetic polymers, biopolymers offer much more diverse 
chemistries. For example, in protein and peptide engineering there are 20 different 
natural amino acids and other unnatural amino acids to choose from. Precise chain-
length control of biopolymers is another advantage over synthetic polymers.  
In this dissertation work, combinations of different types of biopolymers were 
investigated in order to create materials with the desired structural and mechanical 
properties in an effort to mimic natural vertebrate extracellular matrix. The types 
investigated include natural polysaccharides and engineered oligopeptides. Interest in 
polysaccharides as biomaterials stems from their structural and biochemical 
similarities to glycosaminoglycans (GAGs). GAGs are long, unbranched 
polysaccharides and are an important component of the connective tissue. They 
attract water molecules, which is what provides tissue resistance to pressure. Peptides 
are another family of biopolymers that have attracted interest as tissue scaffold 
materials. Peptides have the ability to self-assemble into interwoven fibers which 
confer mechanical rigidity to materials. Described here in more detail are the 
biopolymers utilized in this work. 
1.1.1 Polysaccharides 
 Alginate is one of the most commonly used biopolymers. It is used in a 
variety of medical applications including cell encapsulation and delivery because it is 
commercially available, gels under mild conditions and has relatively low 
cytotoxicity. Alginates are naturally derived polysaccharide block copolymers 
composed of regions of β-D-mannuronic acid monomers (M-blocks), regions of α-L-




monomer depends on the species of seaweed used for alginate isolation (8). Alginate 
gels are formed when divalent cations such as calcium and magnesium interact with 
negatively charged G-blocks to form ionic bridges between different polymer chains. 
As a result, the mechanical properties and pore size of alginate gels can be easily 
controlled by varying the M to G ratio, the molecular weight of the alginate and the 
type of divalent cation selected for cross-linking (9). The molecular weight of 
alginate used in this work ranges from 350 to 450 kDa.  
Cellulose is an inexpensive, readily available biopolymer in part because it is 
the most abundant organic polymer in the world (10). Cellulose can be easily 
modified with acetate, methyl or hydroxypropyl groups to name a few, which makes 
it desirable as a biomaterial (11). It is a linear polysaccharide composed of D-glucose 
units linked by glycosidic bonds where every other glucose residue is rotated about 
180° (12,13). One such modified cellulose, hydroxypropylcellulose (HPC), is a 
neutral and water-soluble cellulose ether with a unique combination of properties 
including thermoplasticity, water solubility and surface activity (14). The advantages 
of cellulose ethers are that they are biocompatible and hence can be used for many 
pharmaceutical purposes (15). The molecular weight of HPC is ~80 kDa. 
Chitosan has been investigated for many different tissue engineering 
applications because it is structurally similar to GAGs found in the extracellular 
matrix. Chitosan can also be degraded by enzymes, giving it desirable biodegradable 
properties (16). It is a linear polysaccharide made of D-glucosamine and N-acetyl-D-
glucosamine derived from chitin. Chitin is a natural polysaccharide found particularly 




usually varies from 75% to 90% and the molecular weight ranges from 100 to 1000 
kDa (8). Positively charged chitosan is soluble in dilute acids which protonate the free 
amino groups. 
Chondroitin sulfate is one of the most abundant GAGs, found in cartilage, 
synovial fluid, bone, and heart valves (18). Chondroitin sulfate is a component of 
proteoglycans, covalently linked to a protein core (19). It is made of repeating 
disaccharide units of D-glucuronic acid and N-acetyl galatosamine, which are 
sulfated at either 4- or 6-positions (20). Chondroitin sulfate is a negatively charged 
polysaccharide, with a molecular weight of ~20 kDa. The benefit of using GAGs as 
biomaterials is having a material that can bind to and modulate growth factors and 
cytokines and is also involved in cell adhesion, proliferation and differentiation (21). 
Moreover, GAGs degrade to non-toxic oligosaccharides. These characteristics 
together with their defined physical and chemical characteristics make them very 
interesting biopolymers. 
Also known as animal starch, glycogen is a neutral biopolymer made 
exclusively of D-glucose units. As a biodegradable material, glycogen is excellent 
since it degrades to simple glucose monomers. Glycogen is a polymer of α(1→4) 
glycosidic bonds, linked with α(1→6)-linked branches (22). Glycogen is a neutral 
polysaccharide with a molecular weight ranging from 400 kDa to millions of kDa, 
depending on the amount of branching and polymerization (23). In the body, 





Oligopeptide biopolymers are attracting interest as biomaterials due to their 
biodegradable, programmable and bioresorbable nature. Unlike synthetic polymers, 
oligopeptides can be made with precise control over sequence, chain length and 
stereochemistry. Oligopeptide-based networks with viscoelastic properties have been 
designed for various biomedical applications (24). Oligopeptide hydrogels have often 
been used to promote growth and proliferation of a variety of cell types, including 
chondrocytes, hepatocytes, endothelial cells, osteoblasts, neuronal cells and stem cells 
(25). Additionally, oligopeptides can be designed with sequences that promote cell 
activities such as attachment and proliferation. Commercially available L-protein 
(e.g., MatriGel
TM
) and L-oligopeptide (e.g., PuraMatrix
TM
) hydrogels have been used 
to mimic the ECM for cell culture applications. 
1.1.3 Oligopeptide-Polysaccharide Composite Materials 
Since the ECM contains both proteins and polysaccharides, groups have 
developed composite materials from peptides and polysaccharides in an effort to 
make better ECM mimetics. For Yamada et al., addition of a laminin active peptide 
into agarose gels resulted in a matrix that could support both the 2D and 3D culture of 
a variety of cells (26). This group also observed improvements in cell behavior when 
peptides were incorporated in chitosan and alginate gels (27). Conjugation of heparin, 
a linear glycosaminoglycan, to peptides such as collagen, gelatin and fibrin has been 
highly attractive since these conjugations sequester growth factors and prevent their 




were created with interesting mechanical properties. Future cell studies may show 
whether these composite materials can improve cell behavior and growth as well. 
1.2 Mechanical Testing in Biomaterials Research 
1.2.1 Compression-Tensile Testing 
The measurement of the mechanical behavior of a sample under compression 
and tension can be performed to provide basic biomaterial mechanical data that is 
critical for material design and performance assessment. The requirements for 
compression and tensile strength values and the methods for testing these properties 
are specified in various standards (i.e., ASTM) for a wide variety of biomaterials.  
The compression test is a method for determining the behavior of biomaterials 
under a compressive load. Compression tests are performed by loading the sample 
between two plates, and then applying a force to the sample by moving the plates 
together. During the test, the sample is compressed and deformation versus the 
applied load is recorded. The compression test is used to determine yield point, yield 
strength, and compressive strength.  
The tensile test is a method for determining behavior of biomaterials under 
tensile loading. The tests are conducted by fixing the sample into the test instrument 
and then applying a force to the sample by separating the testing machine crossheads. 
The crosshead speed can be varied to control the rate of strain in the test sample. Data 
from the tests are used to determine yield strength and elastic modulus. Measurement 
of the sample dimensions after testing also provides elongation values to characterize 




1.2.2 Oscillatory Rheometry 
An oscillatory rheometer is a device that can be used to measure the viscoelastic 
properties of soft biomaterials. The basic principle of an oscillatory rheometer is to 
make cyclic shear deformations in the sample and then measure the resulting stress 
responses. The tests are conducted by placing the sample between two plates. While 
the bottom plate remains stationary, a motor rotates the top plate, which imposes a 
time dependent strain on the sample. Simultaneously, the time dependent stress is 
quantified by measuring the force that the sample imposes on the top plate. Common 
measurements include time-sweep, which measures time-dependent linear 
viscoelastic moduli, G'(ω) (elastic modulus) and G"(ω) (viscous modulus), frequency-
sweep, which shows material dependence on angular frequency and strain-sweep, 
which measures biomaterial strain yield values (γyield). 
1.2.3 Compression-Tensile testing vs. Oscillatory Rheometry 
Both compression-tensile testers and rheometers are excellent choices for 
biomaterial mechanical testing. Rheometers are a better choice for testing very soft 
materials since these materials can be difficult to work with in a compression-tensile 
tester. Rheometry also allows one to monitor material stiffness changes over time, 
which could not be as easily done using a compression-tensile tester. However, when 
working with stronger materials, compression-tensile testers provide a wider range of 
mechanical tests. Because rheometers measure shear moduli and compression-tensile 
testers measure Young’s moduli, these two instruments can also complement each 




1.3 Small-Angle Scattering in Biomaterials Research 
Small-angle scattering (SAS, angle ~0-2˚) has become a powerful tool for 
elucidating the structure of biomaterials. SAS is a scattering method based on the 
small deflection of collimated radiation away from the straight path after it interacts 
with structures that are larger than the wavelength of the radiation (33).  The “angle” 
in SAS refers to the angle of radiation deflection. SAS techniques can give 
information about the shape and size of structures in a sample. SAS is used more 
often in biomaterials research than techniques like wide-angle scattering (WAS, angle 
~2-90˚) because WAS tells about the amount of crystallinity within a sample. Often, 
biomaterials are fairly amorphous so this technique is not very informative. Small-
angle X-ray scattering (SAXS) and small-angle neutron scattering (SANS) are two 
SAS techniques, each with their own advantages and disadvantages. Both techniques 
have been used extensively to characterize biomaterials and are described in more 
detail below. 
 
Figure 1.1: Small-angle scattering pictorial representation of how x-rays are scattered 
and detected in the presence of a sample. This image is taken from H. Schnablegger 




1.3.1 Small-Angle X-ray Scattering (SAXS) 
SAXS is a widely used technique in the biomaterials community. It is 
especially used to determine basic structural characteristics such as material 
correlation length and fiber mass fractal dimension. Gamani et al. used SAXS to 
characterize crosslinked hylaronan. Using an I(q) vs. q plot, they determined the 
polymer junction zone for each gel type (34). SAXS was also used to study how the 
chemical compositions and concentrations of calcium-alginate gels affected their 
structures. It was found that lateral association of chain segments, which dictates 
junction zone lengths, depends on a number of material factors elucidated by SAXS 
(35). Shinohara et al. used SAXS to investigate the structure of slide-ring gels in 
various solvent types. They were able to see a “pulley effect”, a unique property of 
their gels, by simply examining the shape of the raw scattering data (36). Tada et al. 
used SAXS to study the change in structure of curdlan gels over time (37). SAXS was 
also used to examine changes to hydroxyapatite size in bone after extreme heating 
(38). 
1.3.2 Small-Angle Neutron Scattering (SANS) 
SANS is another scattering technique used in biomaterials characterization. Since 
there is a large difference between neutron scattering lengths of hydrogen and 
deuterium, contrast variation is often used in SANS studies for selective labeling. 
Markarian et al. used SANS contrast matching to study single chain dimensions 
of novel materials made from sulfonated poly(styrenesulfonate) and 
poly(diallyldimethylammonium chloride) at different ionic strengths (39). Others use 




SANS and ultra small-angle neutron scattering (USANS) to measure silica 
nanoparticle dispersion in dental nanocomposites (40). Luk et al. characterized the 
distribution of water in semicrystalline and amorphous polymers (41). Feuz et al. 
determined the conformations of poly(L-lysine)-graft-poly(ethylene glycol) molecular 
brushes (42). Still others used SANS in conjunction with rheometry to measure the 
structural response of fibrin gel to shear deformation (43). 
1.3.3 SAXS vs. SANS 
The setup of the SAXS instrument we used at Argonne National Lab allowed us 
to take measurements of samples very quickly (0.2 s), which made time-dependent 
structural studies possible. These studies were not possible with SANS. Smaller 
sample size and sample preparation in H2O are other practical advantages of SAXS. 
SANS samples must be prepared in D2O. In addition to SAXS, we also used SANS to 
elucidate structural features of our hydrogels. The advantage of the SANS instrument 
we used at the National Institute of Standards and Technology (NIST) compared with 
the SAXS instrument was its much larger maximum resolution. The maximum 
resolved size for the SAXS instrument was ~500 Å, while the maximum resolved size 
for SANS was ~2000 Å, which allowed us to explore structural features at a larger 
scale.  
1.4 Manipulating Chirality in Biomaterials Research 
The term chirality is used to describe the structural property of an object that is 
non-superimposable on its mirror image. Interestingly, biomacromolecules are 




polysaccharides and nucleic acids contain exclusively D-sugars. As a result, 
biochemical interactions within the body are chirality-dependent (44).  
Some researchers have taken advantage of these chirality-dependent interactions 
by creating oligopeptide-based hydrogels that contain D-amino acids. Luo et al. found 
that oligopeptides made of D-amino acids could tolerate high temperatures (45) and 
were resistant to protease digestion (46).  Nagy et al. found that heterochiral 
hydrogels containing some D-oligopeptides have higher elastic moduli than the parent 
homochiral hydrogels (47). Dzwolak et al. found that poly(D-lysine) + poly(L-lysine) 
form amyloid-like fibrils while each individual enantiomer remains a clear solution 
(48).  We found that homochiral (D or L) hydrogels confer a mechanical advantage 
while heterochiral hydrogels confer a kinetic advantage (49).  
In this dissertation work, biomaterial chirality was exploited in two different 
ways. First, molecular chiral selectivity was used to create novel oligopeptide-
polysaccharide hybrid materials with different mechanical properties. Because 
polysaccharides are made of D-sugars, which are known to have a stronger affinity 
for L-amino acids compared with D-amino acids, we hypothesized that materials 
made of D-sugars and L-amino acids would have different properties than materials 
made of D-sugars and D-amino acids. Indeed, hybrid materials composed of D-
polysaccharides and L-oligopeptides were found to be mechanically stronger than 
materials composed of D-polysaccharides and D-oligopeptides. This phenomenon 
helps to explain, from a mechanical viewpoint, why sugars and amino acids in 




Second, material chirality was manipulated in conjunction with material charge to 
create new hydrogels that could support mesenchymal stem cell attachment and 
growth. It has been suggested that oligopeptides made of D-amino acids are more 
resistant to enzyme degradation and therefore could theoretically prolong hydrogel 
residence time in the body (46). The problem with this approach is that cells also have 
more difficulty recognizing, attaching to and proliferating on D-synthetic polymeric 
materials compared with L-synthetic polymeric materials (50,51).
 
Since many cellular 
activities are also governed by charge, we hypothesized that charge could improve 
cell recognition and behavior on D-oligopeptide-based hydrogels. In fact, negative 
charge does improve mesenchymal stem cell attachment and proliferation on D-
oligopeptide-based hydrogels. This means that material chirality, in conjunction with 
charge, can be manipulated to create oligopeptide-based materials that are more 
enzyme resistant, yet still supportive of mesenchymal stem cell attachment and 
proliferation. 
1.5 Dissertation Overview 
This work is a combination of projects that helps to elucidate the mechanical and 
structural properties of novel biopolymer-based hydrogels and how some of these 
biopolymer properties affect mesenchymal stem cell behavior. In Chapter 2, we 
examined how interactions between charged polysaccharides create networks with 
different mechanical and structural properties. In Chapter 3, we studied how 
interactions between charged oligopeptides and charged polysaccharides create 
hydrogels with different mechanical and structural properties. In Chapter 4, we 




measuring the mechanical and structural properties of the resulting oligopeptide-
polysaccharide hydrogels. In Chapter 5, we looked at how human mesenchymal stem 










Networks made from chitosan and alginate have been utilized as prospective 
tissue engineering scaffolds due to material biocompatibility and degradability. 
Calcium (Ca
2+
) is often added to these networks as a modifier for mechanical strength 
enhancement. In this work, we examined changes in the bulk material properties of 
different concentrations of chitosan/alginate mixtures (2, 3, or 5% w/w) upon adding 
another modifier, chondroitin. We further examined how material properties depend 
on the order the modifiers, Ca
2+
 and chondroitin, were added. It was found that the 
addition of chondroitin significantly increased the mechanical strength of 
chitosan/alginate networks. Highest elastic moduli were obtained from samples made 
with mass fractions of 5% chitosan and alginate, modified by chondroitin first and 
then Ca
2+
. The elastic moduli in dry and hydrated states were (4.41 6 0.52) MPa and 
(0.11 6 0.01) MPa, respectively (Figure 2.3, Appendix Table A1). Network porosity 
and density were slightly dependent on total polysaccharide concentration. Average 
pore size was slightly larger in samples modified by Ca
2+
 first and then chondroitin 
and in samples made with 3% starting mass fractions. Here, small-angle neutron 
scattering (SANS) was utilized to examine mesh size of the fibrous networks, mass-
fractal parameters and average dimensions of the fiber crosssections prior to freeze-
drying. These studies revealed that addition of Ca
2+




increased fiber compactness and thickness, respectively. Together these findings are 
consistent with improved network mechanical properties of the freeze-dried materials. 
2.2 Introduction 
Chitosan has become one of the most commonly utilized biopolymers in 
biomaterials research. This cationic polysaccharide has many attractive qualities and 
is abundantly found in nature (52). Chitosan has been widely studied for tissue 
engineering applications because of its biocompatibility and biodegradability. Its 
degradation products are glucosamine and N-acetyl glucosamine, amino sugars 
naturally found in the human body. The hydrophilic surface of chitosan has been 
shown to promote cell adhesion, proliferation, and differentiation (53-55). Chitosan is 
also versatile; it is easily moldable and has many functional groups that can be 
modified to tune material properties (56). However, by itself chitosan is mechanically 
weak and swells to disassembly in aqueous environments (57).  
Alginate is an anionic polysaccharide that can electrostatically interact with 
cationic chitosan (58). Upon interaction, alginate and chitosan form fibers which 
create a gel-like, solid material. This material can be freeze-dried and mechanically 
tested. Like chitosan, alginate is a widely used biocompatible polymer, which is 
known to support the proliferation of cells both in vitro and in vivo (59, 60). 
However, on its own alginate is a viscous, weak material. When used as a component 
in scaffolds, alginate is often modified with divalent cations like Ca
2+
 to create a 
strong gel with a characteristic egg box structure (61).  
A number of networks have been made using combinations of chitosan and 
alginate with Ca
2+




freeze-drying the mixtures to create novel biomaterials. Uses for these networks 
include bone replacements (62),
 
liver replacements (63) and medicated wound 
dressings (64). These studies have examined chitosan-alginate networks at low 
polysaccharide mass fractions (0.05% to 2.4%), but give valuable insight about 
network characteristics such as tunability and cell compatibility. The strongest 
chitosan-alginate networks to date were made with a mass fraction of  2.4% chitosan 
and a mass fraction of 2.4% alginate and had a dry compressive elastic modulus of 
(2.56 ± 0.41) MPa (62).  These networks could support osteoblast attachment, 
proliferation and also calcium deposition. Here, the potential of the chitosan-alginate 
networks as load-bearing biomaterials was demonstrated. However, these data lacked 
the important mechanical characteristics in the biologically relevant hydrated state. 
Therefore, more studies are necessary.  
In addition to alginate, chitosan can interact with glycosaminoglycans (GAGs) 
which are also anionic polysaccharides. GAGs are valuable because they can 
facilitate the migration and proliferation of progenitor cells promoting tissue 
regeneration (65, 66). Chondroitin sulfate is one kind of commercially available 
GAG. We found that this anionic polysaccharide creates fibrous, elastic networks 
with the cationic chitosan upon mixing. Chitosan-chondroitin networks have been 
used for the controlled release of platelet-derived growth factor for bone regeneration. 
In vitro drug release could be controlled by adjusting the ratio of chitosan to 
chondroitin (67).  
To improve the mechanical properties of the scaffolds, we hypothesize that 






network could increase electrostatic interactions and improve its overall strength and 
flexibility.  Further, we examined the effect of the order of adding each of the two 
modifiers, Ca
2+
 and chondroitin, on the mechanical strength of the network. To this 
end, three types of networks were prepared: type A, which are chitosan/alginate 
networks with Ca
2+
 as the sole modifier; type B, which are chitosan/alginate networks 
with Ca
2+
 added as the 1
st
 modifier and chondroitin added as the 2
nd
 modifier; type C, 
which are chitosan/alginate networks with chondroitin added as the 1
st
 modifier and 
Ca
2+
 added as the 2
nd
 modifier.  The resulting freeze-dried networks were tested for 
their compression and tensile strengths.   
To promote cell proliferation and migration in vivo, networks should have 
high porosity, suitable and non-uniform pore size, and highly interconnected pore 
structure in addition to biocompatibility and biodegradability (68-70). Therefore, 
network porosity, density and pore size of the freeze-dried materials were examined 
to determine the effect of the polysaccharide content, the addition of a 2
nd
 modifier, as 
well as the addition order of the two modifiers, on these properties. 
It would be reasonable to suggest that mechanical strength of the freeze-dried 
polysaccharide scaffolds would depend on the structural characteristics of the 
polysaccharide networks formed in solution when mixing the components prior to 
freeze-drying.  Therefore, to aid our understanding of the interactions between the 
modifiers and the chitosan/alginate scaffold, small-angle neutron scattering (SANS) 
in solution was used to investigate the impact of the addition of modifiers Ca
2+
 and 
chondroitin individually on the structural features of the chitosan/alginate network.  




individual fiber and the polysaccharide network as a whole are translated into the 
bulk material properties upon freeze-drying. 
 
Figure 2.1: Procedures for making the three types of networks, A, B and C.  Each 
network underwent lyophilization twice. x% chitosan was mixed with x% alginate in 
a 1:1 volume ratio. Type A & B samples were made by adding Ca
2+
 to the chitosan-
alginate mixture at a volume ratio of 10:1 chitosan-alginate:CaCl2. Type A & B 
samples were lyophilized and then soaked in ultrapure H2O and a mass fraction of 2% 
chondroitin respectively. Type C samples were made by adding chondroitin to the 
chitosan-alginate mixture at a volume ratio of 6:1 chitosan-alginate:chondroitin. Type 
C samples were lyophilized and soaked in a mass fraction of 1% CaCl2. 
 
2.3 Materials and Methods 
2.3.1 Materials 
Low molecular weight chitosan (50 to 190 kDa, Sigma-Aldrich), alginic acid 
sodium salt (350 to 450 kDa, Acros Organics), bovine chondroitin sulfate sodium salt 
(~20 kDa, Pfaltz & Bauer), hydrochloric acid (HCl, VWR), ammonium hydroxide 
(NH4OH, Mallinckrodt Baker), ethanol (EMD) and calcium chloride dihydrate 




2.3.2 Preparation of Networks for Mechanical and Imaging Studies 
Solutions of mass fractions 2%, 3% and 5% chitosan were prepared in a mass fraction 
of 2% HCl in ultrapure water (18.2 MOhm, 2 μm cellulose filter) while solutions of 
mass fractions 2%, 3% and 5% alginate were prepared in a mass fraction of 2% 
NH4OH. Mass fractions of 1% CaCl2 and 2% chondroitin solutions were prepared in 
ultrapure water (18.2 MOhm, 2 μm cellulose filter). To prepare sample type A 
(Figure 2.1), alginate and chitosan were mixed together at equal concentrations and 
equal volumes. Type A samples were made at three polysaccharide concentrations by 
mixing mass fractions of 2% chitosan with mass fractions of 2% alginate, mass 
fractions of 3% chitosan with mass fractions of 3% alginate and mass fractions of 5% 
chitosan with mass fractions of 5% alginate, with the resulting samples labeled as 2A, 
3A and 5A, respectively.  The electrostatic interactions between chitosan and alginate 
upon mixing resulted in fibrous, gel-like materials. After chitosan and alginate 
mixing, the 1
st
 modifier, 1% mass fraction CaCl2 solution, was added at a volume 
ratio of 10:1 chitosan-alginate:CaCl2 for all type A samples. The samples were then 
placed in a -20°C freezer overnight and then lyophilized. After lyophilization, dried 
type A samples were soaked in ultrapure water at room temperature for 30 minutes. 
Samples were frozen at -20°C and lyophilized again. At this point, they were ready 
for testing. Type B samples (Figure 2.1) were also made using the same chitosan and 
alginate mixing concentrations. Again, the first modifier CaCl2 was added. Dried type 
B samples were then soaked in the 2
nd
 modifier 2% mass fraction chondroitin at room 
temperature for 30 minutes. The soaked samples were frozen at -20°C and lyophilized 




chondroitin as the first modifier at a volume ratio of 6:1 chitosan-alginate:chondroitin 
and 1% mass fraction CaCl2 as the 2
nd
 modifier. For compressive testing, the dried 
samples were sliced into 12 mm thick dry cylinders. The diameter for each dry 
cylinder was approximately 20 mm. For tensile testing, the same sample-making 
procedure was used except samples were sliced into rectangular plates, 10 mm wide 
and 40 mm long and 2 to 3 mm thick. Finished samples were completely dry, solid 
materials. Figure 2.2 shows a representative image of the cylinder-shaped version of 
these freeze-dried samples. 
 
Figure 2.2: A representative image of the cylinder-shaped version of the freeze-dried 
samples. 
2.3.3 Mechanical Testing 
Mechanical strength of the freeze-dried networks was assessed using a 
Tensilon tensile-compressive tester (RTF-1310, Orientec, Japan) with a 50 N load 
cell. For compressive testing, the guidelines for mechanical testing from ASTM 
D5024-95a were used as described (62, 71). Briefly, the freeze-dried samples were 
hydrated to saturation and compressed to 30% of their original thicknesses with a 
constant crosshead speed of 0.4 mm/min. For tensile testing, rectangular freeze-dried 
networks were hydrated to saturation and elongated until rupture at a crosshead speed 




slopes of their respective stress-strain curves. In order to obtain the most realistic 
mechanical values, samples were tested in a hydrated state. However, the strongest 
sample (5C) was compressed in a dry state in order to compare with other reported 
chitosan-alginate strength values (62). The ultimate tensile strength was calculated by 
dividing the maximum load value by the material cross-section. The strongest sample 
(5C) was also put under tension in a dry state to determine the difference between dry 
and hydrated states. Five samples were used for each mechanical test. Mechanical 
testing results are presented as the average of five sample tests with the standard 
deviation reported as the error. 
2.3.4 Scanning Electron Microscopy 
10  10 mm pieces of each dried sample were examined using Scanning 
Electron Microscopy (SEM, Hitachi SU-70). Samples were placed on an SEM sample 
holder and coated with a thin layer of gold (≈30 nm) using a Sputter Coater (Anatech 
Hummer X). Average pore diameters of the networks were determined using the NIH 
image analysis program, ImageJ (73). Six images from each sample were taken for 
analysis of the entire sample surface. Every pore was measured in all images. 
2.3.5 Material Porosity and Density 
A liquid displacement method described by Zhang et al. was modified and 
used to determine the polysaccharide network porosity and density (71).  Dried 
samples of dimensions 7 mm  7 mm  7 mm were weighed (W) and then placed in a 
known volume of liquid (V1). Air was evacuated from the samples followed by re-




close to 20 Torr. Air evacuation was done using a modified graduated cylinder, fitted 
with an attachment for vacuum pumping. The volume of the liquid including the 
saturated network (V2) was measured. The saturated network was then removed and 
the remaining liquid volume (V3) was measured. The original method used ethanol to 
determine porosity because it does not cause network swelling. However, we found 
ethanol evaporation to be a problem during air evacuation. Instead, heptane was used 
as the displacement liquid. Heptane did not have noticeable evaporation during air 
evacuation and did not affect network swelling.  The density (ρ) and porosity (ε) of 
the networks were then calculated using the following equations.  
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2.3.6 Preparation of Networks for SANS Study 
Chitosan, alginate, chondroitin and calcium chloride solutions were prepared 
in D2O to enable adequate contrast between the hydrogen-rich networks and the 
solvent. Solutions of mass fraction 2% chitosan were made in D2O containing a mass 
fraction of 2% HCl and solutions of mass fraction 2% alginate were made in D2O 
containing a mass fraction of 2% NH4OH. Solutions of a mass fraction of 1% 
chondroitin and 0.5% CaCl2 were each made in D2O. Five samples were prepared for 
measurement (Table 2.1).  The calcium containing sample was made by mixing a 
mass fraction of 2% chitosan with a mass fraction of 2% alginate in equal volumes 




chondroitin containing sample was made using the same chitosan and alginate 
mixture and chondroitin was added at a volume ratio of 6:1 chitosan-
alginate:chondroitin. Mixtures were prepared within titanium sample cells with 30 
mm diameter quartz windows and a 2 mm path length.  Samples were prepared within 
12 hours of measurements. Of note, the samples for SANS experiments were not 
Table 2.1: Structural data from SANS analysis. Correlation length (lc), mass-fractal 
(d), mass-fractal prefactor (B) and radius of gyration of the cross-section (Rc), were 
analyzed for chitosan/alginate samples. Each mixture was made with equal volumes 
of a mass fraction of 2% chitosan and a mass fraction of 2% alginate. The calcium-
containing sample was made by adding Ca
2+
 to the chitosan/alginate mixture at a 
volume ratio of 10:1 chitosan-alginate:CaCl2 (0.25% CaCl2). The chondroitin-
containing sample was made by adding chondroitin to the chitosan/alginate mixture at 
a volume ratio of 6:1 chitosan/alginate/chondroitin (0.5% chondroitin). The B for 
chitosan and alginate could not be calculated due to low scattering values. 
Samples lc (Å) d B Rc (Å) 
2% chitosan 147 ± 8 3.0 ± 0.3 - 83 
2% alginate 245 ± 9 2.6 ± 0.3 - 88 
2% chitosan+ 2% alginate 134 ± 5 2.9 ± 0.2 4.6 × 10
-4
 109 
2% chitosan + 2% alginate + 0.25% Ca
2+
 120 ± 5 2.8 ± 0.2 1.0 × 10
-4
 92 




freeze-dried as opposed to the samples used for SEM, and mechanical, porosity and 
density studies.  We have performed SANS experiments with polysaccharide 
networks in solution before they were freeze-dried in an attempt to get an insight on 
how the structural characteristics of the polysaccharide networks at the nanoscale 
level (or the level of individual fiber) are further translated into the bulk material 
properties.  Due to dimensional hindrances of 1-mm quartz-titanium sample cell used 
in SANS studies, freeze-dried samples could not be loaded. We were also limited to 
lower concentrations of polysaccharides which contained only one modifier for each. 




modifiers in the restricted environment of the sample cell hampered the extension of 
our experiments to wider concentration ranges and the addition of a second modifier.  
However, despite the above limitations, we strongly believe that SANS studies 
provide solid support for the results of bulk material testing and in some sense could 
serve as a basis for explanation of the observed material properties. 
2.3.7 SANS Structural Analysis 
Structures of the networks listed in Table 2.1 were investigated using the 30 m 
SANS instrument (NG-3) at the National Institute of Standards and Technology 
(NIST) (74).  Monochromatic neutrons at λ = 6 Å with a wavelength spread (Δλ/λ) of 
0.14 were detected on a 64 cm  64 cm two-dimensional detector. Data on SANS 
intensity were collected with a Q-range from 0.001 Å
-1
 to 0.4 Å
-1
 at 25°C.  Q is the 
scattering vector and is related to the wavelength λ and the scattering angle   by 






Q        (2.3) 
The instrument has pinhole geometry. Scattering intensities were normalized 
using direct beam transmission measurements and were reduced according to 
published protocols (75, 76). Processing of the data was performed using IGOR 
6.2/IRENA software (77) to obtain characteristics at the levels of fiber building and 
packing.  To estimate the density of the cross-linking networks in the samples, the 
Debye-Bueche model (78) was used in the following form 
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the spatial extent of the cross-linking regions and reflects the average mesh size.  A 
larger correlation length value correlates with a larger average mesh size (79).  
Mass-fractal dimensions were estimated using the fractal model (Dr. A. Allen, 
NIST) implemented in IRENA and described in detail within the program. Fractal 
analysis is often used to analyze materials that have a repetitive unit, an elementary 
“building brick” which is appropriate for our oligopeptide/polysaccharide systems. 
Fractal analysis is done in the high-Q region of the I(Q) vs. Q plot. This region 
corresponds to a range of distances smaller than the size of the scattering objects so 
that the scattered neutrons are probing the local structure of the hydrogel network. 
The fractal dimension (d) in mass-fractal analysis is a number ranging from 1 to 3, 
and defines the structural characteristics of the “building brick.”  For instance, d is 1 
in the case of stiff rod-like repetitive units; d is 2 for the Gaussian-coil-shaped 
structures, and d is 5/3 for the swollen Gaussian-coils in a good solvent, whereas a 
value of 2 or greater corresponds to a degree of branching (80).  Scattering from a 
mass-fractal is given as 
dBQQI )(     (2.5) 
where d is the slope of the LogI(Q) vs. LogQ plot (in the Appendix, Figures A2-A6) 
and B is the prefactor indicative of dimensional characteristics of a repetitive unit 
reflecting its degree of swollenness.     
The networks under study are formed of fibers with one dimension (length) 
much longer than the other two (cross-sectional dimensions), and the length of the 
fibers exceeded the resolution limit (Qmin) of the scattering data (in our case Qmin ~ 
0.001 Å
-1




2000 Å).  Therefore, we analyzed the scattering data in terms of the cross-sectional 
dimensions of the scattering particles using standard approach of multiplication of 
I(Q) by Q, thereby essentially removing the information about the length of the 
scattering particles (81).  
Characteristics of individual fibers were acquired with the ATSAS software 
(82). The radius of gyration of the cross-section (Rc) was determined by calculating 
the pair distance distribution function of the fiber cross-section (Pc(r)) using indirect 
Fourier transform methods in GNOM. The radius of gyration of the cross-section 
describes the average distance of all area elements of the cross-section from the 
center of scattering density. The r value at Pc(r) = 0 gives the maximum linear 
dimension for the cross-section of the scattering particle, dmax. The radius of gyration 
of the cross-section of the scattering particle, Rc, is derived from the second moment 
of Pc(r). 
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Since the scattering intensity is directly proportional to the concentration (in mg/mL) 
and the molecular weight (in Da) of the constitutive molecules, to normalize pair-
wise distribution functions of the cross-section, Pc(r), data for each polymer sample 
were divided by the sum: 
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where i is the number of polysaccharide components Ci is the concentration of 
corresponding component (in mg/mL) and iM  is the average molecular weight of the 
i-th polysaccharide (in Da). 
2.3.8 Statistical Analysis 
Five experiments were performed per sample for each mechanical, porosity 
and density test. Six SEM images from each sample were taken for analysis of the 
average pore size over the entire sample surface. The Tukey-Kramer method was 
used to determine significant differences between the average pore sizes of different 
sample sets. One set of SANS data was obtained for structural analysis. SANS 
analysis was performed on single samples. A Student’s unpaired t test or analysis of 
variance (ANOVA) was carried out to determine the statistical significance (p < 0.05) 
of differences in material mechanical properties, porosity and density. 
2.4 Results 
2.4.1 Mechanical Testing: Compressive Testing 
Shown in Figure 2.3, the elastic moduli for hydrated samples increased with 
increasing polysaccharide concentration. There was a statistically significant (p < 
0.01) difference between type C elastic moduli at 5% concentrations compared with 
type C at 2 and 3% concentrations, demonstrating network stiffness is affected by 
polysaccharide concentration for type C networks. Type A and B networks also 
demonstrate a trend of elastic modulus increase with polysaccharide concentration 
increase. All type A moduli had statistically lower values than comparative type B 




stiffness since the type A samples did not contain chondroitin. Additionally, samples 
3C and 5C had statistically higher elastic moduli (p < 0.01) compared with samples 
3B and 5B. It appears the order of component addition only significantly affects the 
elastic moduli for the two higher concentration samples.  This result may be due to 
incomplete penetration of chondroitin into the polymer network at higher 
polysaccharide concentrations if chondroitin is added as the 2
nd
 modifier. The 
inability of chondroitin to diffuse freely may limit electrostatically-driven 
chondroitin-chitosan interactions, which could affect mechanical strength of the 
networks. Unlike chondroitin, Ca
2+
 may be able to overcome steric hindrance because 
of its much smaller size. Furthermore, it was reported that Ca
2+
 diffusion in higher 
concentrations of alginate likely increases the number of cross-linking events which 
improved mechanical strength of alginate hydrogels (83). For comparison with 
reported values, dry 5C samples were compressed as well, with an elastic modulus of 
4.4  0.52 MPa (Appendix, Table A1), giving a significantly larger modulus than the 
largest previously obtained result (2.56  0.41 MPa) (62). 





























Figure 2.3: Elastic modulus of each hydrated sample type. As total polysaccharide 
concentration increased, elastic modulus also increased. Samples are identified by 
mixing order (A, B or C) and by initial mass fractions of chitosan and alginate used 
(2%, 3% or 5%). Mechanical testing results are presented as the average of five 
sample tests with the standard deviation reported as the error. The error bars 
correspond to one standard deviation. Such applies to Figures 2.3, 2.6 and 2.7 as well. 
 
2.4.2 Mechanical Testing: Tensile Testing 
As polysaccharide concentration of hydrated samples increased, network 
tensile strength increased in general (Figure 2.4). Type C samples had the greatest 
ultimate tensile strengths, ranging from 1.8 kPa to 3.2 kPa while type A and B 
samples were significantly less (p < 0.01).  Type B samples were either statistically 
similar or slightly stronger than type A samples in terms of tensile strength.  
Therefore, the addition order of the 2 modifiers is just as important for tensile 
strength as it is for the compressive strength of the networks.  The ultimate tensile 
strength for dry 5C samples was 71.2  4.6 kPa which is about 22 times larger than 
the hydrated tensile strength for 5C (Appendix Table A1, Figure 2.4). 
In summary, mechanical testing shows that, as a modifier, chondoritin can 
indeed significantly strengthen chitosan/alginate networks, provided chondroitin is 
added before Ca
2+


































Figure 2.4: Ultimate tensile strength of each hydrated sample type. Type C samples 
had statistically larger tensile strength values than type B samples possibly due to 
lack of chondroitin diffusion in type B samples. 
 
2.4.3 Material Pore Size, Porosity and Density 
Highly porous and interconnected pore structures are needed to ensure an 
environment conducive to cell proliferation and attachment in addition to allowing 
the free flow of nutrients. SEM images (Figure 2.5) suggest material pore sizes are 
generally very heterogeneous. In Figure 2.6, the histograms also show pore size 
heterogeneity. To determine whether the average pore sizes for each sample type (A, 
B, C, 2, 3 and 5) were statistically significant from each other, the Tukey-Kramer 
method was used. At 95% simultaneous confidence levels, average pore size for 
sample type B was greater than A and C, and sample types A and C were statistically 
equivalent. Lack of chondroitin penetration may have induced the fusion of pores 
during the second freezing event, creating slightly larger pores in type B samples. At 
95% simultaneous confidence levels, average pore size of sample type 3 was greater 





Figure 2.5: SEM images of the nine sample types. Accelerating potential 1.0 kV, 
30.7 mm  30 mm. Sample images depict the heterogeneous nature of the pores. 
Images are identified by mixing order (A, B or C) and by initial mass fractions of 
chitosan and alginate used (2%, 3% or 5%) for the purpose of this work. 
 
Larger pores in type 3 samples may have been due to the diffusion of polysaccharides 
prior to the first freezing. Type 5 samples contained more total polysaccharide 
content and diffusion may have been slow, resulting in slightly smaller pores. 
Conversely, type 2 sample polysaccharides could interact freely and form more 
complex networks consisting of slightly smaller pores. Chung et al. observed a 
similar heterogeneous pore population for chitosan-alginate networks frozen at -20°C 
(63). Regardless of the mechanism, the data show that there is an optimal 
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Figure 2.6: Pore size distributions for each sample. Average pore diameter <D> is 
reported for each distribution. 
 
In general, increased material porosity (Figure 2.7) correlates with smaller 
starting concentrations of polysaccharide. Samples that were made with 2% 
polysaccharide have an average porosity about 15% higher than samples made with 
5% polysaccharide. As for adding chondroitin as an additional modifier, the general 
trend is that it leads to a decrease in porosity as type B and type C samples are 
slightly less porous than type A samples. Type C samples were also slightly less 
porous than type B samples. More complete chondroitin incorporation in type B 
samples may be the reason for this effect. Porosities and pore sizes of these networks 

























Figure 2.7:  Average porosity of each sample. Decreased material porosity correlates 
with increased polysaccharide concentrations. 
 
As expected, density shows the opposite trend of porosity as higher density 
correlates with larger starting concentrations of polysaccharide (Figure 2.8); samples 
that were made with 5% polysaccharide have an average density over two times 
larger than samples made with 2% polysaccharide. As for adding chondroitin as an 
additional modifier, the general trend is that it leads to an increase in density as type 
B and type C samples have higher densities than type A samples.  However, the order 
of chondroitin addition does not seem to affect material density as type B and type C 
























Figure 2.8:  Average density of each sample. Increased material density correlates 
with larger starting concentrations of polysaccharide. 
 
To recapitulate, it seems that when chondroitin is added before Ca
2+
, it 
increases the mechanical strength and reduces the average pore size and porosity, in 
comparison to when Ca
2+
 is added before chondroitin.  However, the addition order 
has no statistically significant effect on the density of the material. 
 
2.4.4 SANS Structural Analysis 
Analysis of the SANS data was performed in an effort to understand how the 
structural differences between polysaccharide networks in solution at the nanoscale 
level and at the level of individual fibers translate into the bulk material properties 
after freeze-drying.  Different SANS parameters characterize different individual 
properties of the fibers or the networks, however, taken together they might form a 
consistent picture of structure-property relationships.  
As a rule, the scattering intensity profile I(Q) vs. Q characterizes the mass 




greater the intensity I(Q).  In general, one might expect that networks comprised of 
higher scattering particles, upon freeze-drying, will produce mechanically stronger 
materials.  Another dimensional parameter which describes the fiber cross-section is 
the radius of gyration of the cross-section Rc, which is obtained from pair-wise 
distance distribution function of the fiber cross-section Pc(r).  A larger Rc 
characterizes a greater cross-section of the polysaccharide fiber, and thicker fibers are 
capable of forming stronger materials when freeze-dried.   
 
 
Figure 2.9: A physical depiction illustrating the network parameters obtained from 
SANS analysis. 
 
One of the important characteristics of the individual fiber is the mass-fractal 
dimension d which defines the structure of the repetitive unit (building “brick”) of the 
fiber. The packing and compactness of this repetitive unit is characterized by mass-




values correspond to greater swollenness of the polysaccharide fiber building unit, 
and greater swollenness results in a weaker material after freeze-drying.  Correlation 
length or mesh size lc defines the properties of the polysaccharide network, and 
smaller values of lc are usually attributable to stronger networks.  An illustrative 
summary which compares the parameters examined in these networks can be seen in 
Figure 2.9. Also, a pictorial explanation of SANS parameters for the polysaccharide 
networks studied in this chapter has been provided (Figure 2.10).  
 
Figure 2.10: Pictorial explanation of SANS parameters. 
 
The measured scattering intensity (Figure 2.11) for each of the networks 
indicates greater scattering from mixed networks compared with pure alginate and 
pure chitosan samples. Increased scattering intensity describes the formation of 
aggregates and is consistent with the development of fibril networks, evidence that 




intensity for the chitosan/alginate/Ca
2+
 mixture was the smallest and the 
chitosan/alginate/chondroitin mixture was the largest.  This is consistent with the 
formation of much larger, stronger scattering assemblies in the presence of 
chondroitin which are capable to reinforce the resulting material after freeze-drying.  
Indeed, when freeze-dried, the scaffolds containing chondroitin demonstrate the 











































Figure 2.11:  I(Q) vs. Q SANS profiles for multi-component biopolymer networks: 
chitosan, cyan; alginate, black; chitosan + alginate, orange; chitosan + alginate + 
CaCl2, violet; chitosan + alginate + chondroitin, light green. Greater I(Q) values 
correspond to larger scattering particles, e.g., chitosan + alginate + chondroitin 
mixture forms the biggest assemblies.  Inset plot shows Guinier plots for rod-like 
particles, lnQ*I(Q) vs. Q
2
, and the linearity in this region confirms the formation of 
elongated fibers in all systems. Color code on inset corresponds to main figure. 
Statistical error bars correspond to one standard deviation and represent error in the 
scattering intensity estimation. Error bars are large at the instrument configuration 
overlap region but are smaller than the plotting symbols at low Q. 
 
The correlation lengths (lc, Table 2.1) for the five samples showed that prior to 




larger than the correlation lengths of chitosan and the three mixtures. The correlation 
lengths for chitosan and the chitosan-alginate mixture are quite similar. The average 
mesh size of alginate thus decreases during the mixing process which suggests the 
presence of chitosan-alginate interactions. Interestingly, the correlation length of the 
Ca
2+
-containing mixture was smaller than the other two mixtures. These results may 
occur due to alginate stiffening upon Ca
2+
 addition, which was known to shorten 
alginate chains. Stokke et al. also observed a similar shortening evident from the 
relationship between scattering intensity and Ca
2+
 concentration in pure alginate gels 
using small angle X-ray scattering (SAXS) (35). Thus, due to such contraction of the 
alginate polymer, the addition of Ca
2+
 created a more densely-packed system (smaller 
correlation length).  Smaller mesh-sized networks, in general, should be expected to 
produce stronger bulk materials after freeze-drying.  Therefore, freeze-dried 
polysaccharide scaffolds modified with Ca
2+
 may demonstrate greater mechanical 
strength. The correlation length or average mesh size for the chondroitin-containing 
mixture was the greatest among the three mixtures. A larger correlation length for the 
chondroitin-containing mixture indicated that addition of chondroitin increased the 
average mesh size of the polysaccharide network. Mesh size increase may be due to 
increased fiber thickness upon chondroitin interaction with chitosan-alginate fibers as 
well as electrostatic repulsion of the negatively charged components. In a system 
where both these modifiers are added, one might expect chondroitin to increase the 
fiber thickness and Ca
2+
 to condense and stiffen those fibers into a stronger, compact 
system. When freeze-dried, this polysaccharide scaffold with two modifiers shows the 
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Figure 2.12:  Pair-wise distance distribution functions, Pc(r), for the cross-section of 
the rod-like fibers of multi-component networks: chitosan, cyan; alginate, black;  
chitosan + alginate, orange; chitosan + alginate + CaCl2, violet; chitosan + alginate + 
chondroitin, light green. Functions with two maxima are characteristic for the 
dumbbell shape of the cross-section.  Value of r in Å where Pc(r) goes to zero defines 
the maximum dimension of the cross-section which for all fibers is around 375 Å. 
 
Mass-fractal dimensions, d, which define the structure of the repetitive unit of 
the fiber for all five samples (Table 2.1) point to the formation of randomly-branched 
swollen polymers (d values from 2.6 to 3.0) (80). Additionally, the power-law 
prefactor (B) from mass-fractal analysis reflects the dimensions and/or the degree of 
swollenness of the repetitive unit and is the smallest for the Ca
2+
-containing samples 
(Table 2.1).  Contraction of alginate upon Ca
2+
 addition decreased the swollenness 
(B) and after freeze-drying this sample may demonstrate greater mechanical strength. 
The addition of chondroitin also reduced the B value slightly compared with the 
chitosan-alginate mixture. The decreased degree of swollenness is also in agreement 
with the results showing chondroitin addition directly translates to the strengthening 




The radius of gyration of the cross-section (Rc), derived from the analysis of 
pair-wise distance distribution function of the cross-section (Pc(r)), can also be found 
in Table 2.1. Here, Rc is the contrast weighted average distance of all area elements of 
the cross-section from the center of scattering density and, in general, it characterizes 
maximum dimensions of the fiber cross-section.  The Rc value for the chitosan-
alginate network is larger than the Rc values of separate chitosan and alginate fibers 
suggesting that upon mixing, chitosan and alginate interact to form a thicker fiber, 
with a larger cross-section than either chitosan or alginate alone. After Ca
2+
 addition, 
the Rc value of the chitosan-alginate network becomes smaller, due to the contraction 
of alginate upon interaction with Ca
2+
.  As mentioned above, such contraction 
simultaneously leads to a more compact and more dense network as evidenced by the 
decrease in mesh size lc and prefactor B (Table 2.1), thus suggesting a stronger bulk 
material upon freeze-drying.  In contrast, after chondroitin addition, the Rc value for 
the chitosan-alginate network becomes larger due to the incorporation of chondroitin 
into the chitosan-alginate network and the thicker fiber that results. In Figure 2.12, the 
pair-wise distance distribution functions of the cross-section Pc(r) are plotted 
together. These functions reflect the probabilities of finding different distances 
between two arbitrary points within the cross-section, and the area under the curve 
characterizes the mass per unit length of the fiber.  The pattern of Pc(r) for all three 
mixtures corresponds to an asymmetrical dumbbell shape of the cross-section, yet the 
shape is more pronounced in the Ca
2+
-containing mixture. Fiber contraction upon 
Ca
2+
 addition may be the reason for this change in shape.  Once again, we see that 
addition of Ca
2+




thickness. Together, these modifiers can increase the fiber density and therefore 
increase the network bulk mechanical properties after freeze-drying. 
To summarize, increased scattering intensity describes the formation of 
aggregates and is consistent with the development of fibril networks, evidence that 
chitosan and alginate interactions have occurred. Additions of both modifiers 
individually change the structure of chitosan-alginate networks in different ways. 
Addition of Ca
2+
 causes the contraction of the network due to Ca
2+
-alginate 
interactions. This contraction increased the stiffness of the fibers. Addition of 
chondroitin causes an increase in fiber thickness due to chondroitin-chitosan-alginate 
interactions. Increased fiber thickness results in greater material density which in turn 
may increase material stiffness and strength. 
2.5 Conclusions 
Tissues such as cartilage, tendons or ligaments exist in mechanically 
demanding environments. In order to repair or replace these materials, it is desirable 
to mimic their mechanical strengths in engineered soft biomaterials. Creating the 
strongest materials possible requires an understanding of how individual network 
components and various conditions affect bulk material properties. In the present 
work, we examined how the addition of chondroitin affected the properties of 
chitosan-alginate networks. Samples containing chondroitin were stiffer and had 
greater tensile strengths than samples without chondroitin. However, the effectiveness 
of chondroitin addition was dependent on the order in which it was added. When 
added after the first lyophilization (type B samples), chondroitin could not diffuse 




where chondroitin was added prior to the first lyophilization (type C samples). 
Effects of total polysaccharide concentration were also studied. Higher concentrations 
were associated with greater mechanical strengths. Porosity and density were notably 
concentration dependent. Pore size was affected by both concentration and order of 
chondroitin addition. Structural analysis of the networks complemented the findings 
in this chapter. Correlation length, dimensional characteristics of the repetitive unit 
and radius of gyration of the cross-section illustrated that chondroitin addition 
increased fiber thickness while Ca
2+
 addition caused fiber contraction thereby 
increasing fiber stiffness. Together, the two modifiers improved network density, 
resulting in greater stiffness and tensile strength. This effort demonstrates the 






Chapter 3: Viscoelastic Properties and Nano-scale Structures of 
Composite Oligopeptide-Polysaccharide Hydrogels 
 
3.1 Abstract 
Biocompatible and biodegradable peptide hydrogels are drawing increasing 
attention as prospective materials for human soft tissue repair and replacement. To 
improve the rather unfavorable mechanical properties of our pure peptide hydrogels, 
in this work we examined the possibility of creating a double hydrogel network. This 
network was created by means of the coassembly of mutually attractive, but self-
repulsive oligopeptides within an already-existing fibrous network formed by the 
charged, biocompatible polysaccharides chitosan, alginate, and chondroitin. Using 
dynamic oscillatory rheology experiments, it was found that the coassembly of the 
peptides within the existing polysaccharide network resulted in a less stiff material as 
compared to the pure peptide networks (the elastic modulus G' decreased from 90 to 
10 kPa). However, these composite oligopeptide-polysaccharide hydrogels were 
characterized by a greater resistance to deformation (the yield strain γ grew from 4 to 
100%). Small-angle neutron scattering (SANS) was used to study the 2D cross-
sectional shapes of the fibers, their dimensional characteristics, and the mesh sizes of 
the fibrous networks. Differences in material structures found with SANS 
experiments confirmed rheology data, showing that incorporation of the peptides 
dramatically changed the morphology of the polysaccharide network. The resulting 




formed less stiff gels because of their markedly greater mesh sizes. Together, these 
findings suggest an approach for the development of highly deformation-resistant 
biomaterials. 
3.2 Introduction 
Self-assembling oligopeptide hydrogels have become increasingly popular 
materials for tissue engineering (85, 86), drug delivery (87, 88) and cell culture 
applications (89).  Flexibility of oligopeptide sequence design and relative ease of 
synthesis make oligopeptide hydrogels highly tunable, both chemically and 
mechanically. Tunability of the oligopeptide building blocks allows for substantial 
manipulation of bulk material properties.  Despite the versatility of oligopeptide 
hydrogels, these materials remain mechanically weak.  Promising methods involving 
cross-linking by enzymatic oxidation (90), electrostatic interactions (91), interplay 
between hydrophilic and hydrophobic interactions (92), and disulfide bonds (93) have 
been used to significantly increase elastic moduli. 
In this chapter we draw upon another approach commonly used in materials 
research in order to modify the material properties of oligopeptide hydrogels, by 
incorporating the fibers of other biopolymers into the oligopeptide fiber network.  By 
designing this composite network, we hoped to create a material with new and/or 
possibly improved visoelastic properties.  Recently, Hosseinkhani et al. created a 
scaffold combining a oligopeptide amphiphile with a collagen sponge in order to 
examine the release of growth factor and the formation of bone in the oligopeptide-
collagen scaffolds in vitro and in vivo (94).  Increased strength and sustained release 




hybrid biomimetic scaffolds for drug delivery as well as for tissue engineering 
purposes. 
In this section, we designed novel biomaterials assembled based upon our 
earlier approach which involves electrostatic interactions, described in chapter two 
(95). The polysaccharide portion of the material was assembled from chitosan, 
alginate and chondroitin.  Previously, we found that the combination of these three 
polysaccharides resulted in a strong, flexible network formed through the electrostatic 
interactions of positively charged chitosan with negatively charged alginate and/or 
chondroitin (95).
 
 The oligopeptide hydrogel portion of the material was comprised of 
one positively charged oligopeptide and one negatively charged oligopeptide.  Based 
on the discovery that oligopeptides with alternating charged/neutral sequence patterns 
could self-assemble into hydrogels (96), we previously developed a modular 
approach to the engineering of oligopeptide-based hydrogels (97-99). Our general 
design separates positively and negatively charged amino acids into different 
oligopeptide chains. As a result of the electrostatic repulsions inherent within each 
oligopeptide module, spontaneous hydrogelation due to slight pH, temperature and 
ionic strength changes are avoided. When mixed, the two oppositely charged 
oligopeptides co-assemble into a hydrodel in phosphate buffered saline (PBS).  The 
polysaccharide networks were premade and then mixed with the oligopeptide pair in 
solution so that the polysaccharide fibers could interact and form a network with the 
oligopeptide pair.  Properties of the polysaccharide and oligopeptide fibrous networks 
were examined as separate materials and mixed together. We hypothesized that since 




oligopeptides is highly likely, thereby increasing the total number of electrostatic 
interactions in this system and creating a material with new viscoelastic properties.  
This study is focused on correlating the structures of separate oligopeptide and 
polysaccharide networks as well as composite oligopeptide-polysaccharide networks 
at the nanoscale level to their bulk viscoelastic properties. To this end, dynamic 
oscillatory rheology experiments probing the mechanical strength, dynamic network 
characteristics as well as the brittleness of each material were performed.  These 
experiments were followed by the analysis of structural characteristics of the fibrous 
networks under study as well as the individual fiber dimensional characteristics using 
small angle neutron scattering (SANS). 
3.3 Materials and Methods 
3.3.1 Materials 
Low molecular weight chitosan (50 to 190 kDa, Sigma-Aldrich), alginic acid 
sodium salt (350 to 450 kDa, Acros Organics), bovine chondroitin sulfate sodium salt 
(~20 kDa, Pfaltz & Bauer), hydrochloric acid (HCl, VWR) and ammonium hydroxide 
(NH4OH, Mallinckrodt Baker) were used as purchased. 
3.3.2 Oligopeptide Design and Synthesis 
Oppositely charged peptide modules have been designed in accordance with 
an earlier approach (97) whereby these co-assemble into a hydrogel when mixed due 
to electrostatic attractions. Both sequences are palindromic, and the N-, C- termini of 
each peptide module are acetylated (Acetyl-) and amidated (-amide), respectively, to 




(lysine, K) and neutral (tryptophan, W; and alanine, A) amino acids, while the 
negative sequence contains alternating negatively charged (glutamate, E) and neutral 
(tryptophan, W; and alanine, A): 
Positive sequence:      Acetyl-K-W-K-A-K-A-K-A-K-W-K-amide   (KWK) 
Negative sequence:    Acetyl-E-W-E-A-E-A-E-A-E-W-E-amide      (EWE) 
Oligopeptides were synthesized on Rink-amide MBHA resin by means of a 
CEM microwave synthesizer using Fmoc solid-phase peptide synthesis (100). All 
amino acids and reagents were dissolved in 100 % dimethylformamide (DMF).  The 
crude peptides were cleaved by a TFA/TIS/H2O (95/2.5/2.5) cocktail for 2 × 2 hours 
and the side chain protecting groups were removed at the same time. TFA was 
removed by rotary evaporation under reduced pressure, and then the crude peptides 
were precipitated and washed twice by cold ethyl ether. 
The crude peptides were dissolved in water and lyophilized before 
purification. Preparative reverse-phase HPLC method was used to purify the crude 
peptides. In the purification of KWK, solvent A was 0.1 % mass fraction HCl in 
water and solvent B was 0.1 % mass fraction HCl in MeOH; in the EWE purification, 
solvent A was 20 mmol/L NH4HCO3 in water (pH 7.0), solvent B was 20 mmol/L 
NH4HCO3 (pH 7.0) in MeOH/water (8:2). Chromatographic method of peptide 
purification: 0-40 % B in 0-60 min, 40-100 % B in 60-90 min with linear gradient for 
each segment was performed. The purity of KWK and EWE was verified by reverse-
phase HPLC analysis (see Appendix figure A8).  The solvents used were the same as 
for the preparative HPLC run.  Molecular weights of KWK and EWE were verified 




Purified peptides were dissolved in phosphate-buffered saline at pH 7.4.  
Concentrations of the individual peptide solutions (16 mmol/L or 32 mmol/L) were 





) (101). All hydrogel measurements were conducted at a final 
concentration of 8 mmol/L of each peptide. 
3.3.3 Dynamic Rheometry Sample Preparation 
Five different samples were prepared and were labeled by their components 
(C = chitosan, A = alginate, D = chondroitin, P = peptides):  chitosan+alginate 
hydrogel (CA), chitosan + alginate + chondroitin hydrogel (CAD), peptide hydrogel  
(P), chitosan + alginate + peptide hydrogel (CAP), and chitosan + alginate + 
chondroitin + peptide hydrogel (CADP).  Stock solutions of chitosan, alginate and 
chondroitin were made in phosphate buffered saline (PBS) at 1.5 % mass fraction.  
Chitosan solution also required the addition of 1 % mass fraction HCl in H2O to 
dissolve.  Stock solutions of both peptides were made in PBS at pH 7.4 at 4.54 % 
mass fraction (32 mmol/L).  All sample preparation procedures and measurements 
were performed at 25 C and the final pH for all samples was 7.4.  
To prepare the CA network, stock solutions of chitosan and alginate were 
diluted to 0.5 % mass fraction by PBS, and equal volumes (1:1), 200 L of each 
diluted solution were mixed together by simultaneous pipetting through a Y-shaped 
connector into the sealed cell of the rheometer.  The measurements of gelation 
kinetics started immediately after mixing.   
To prepare the CAD network, stock solutions of chitosan and alginate were 




fraction chitosan with 143 µL 0.7 % mass fraction alginate in the rheometer cell 
through Y-shaped connector, the mixture was allowed to equilibrate for 2 hours (time 
necessary to build up of CA network estimated from the rheology experiments for 
CA network).  Then 114 µL of chondroitin solution diluted to 0.28 % mass fraction 
(to get 7:1 chitosan/alginate to chondroitin weight ratio) was added to the mixture, 
immediately followed by rheological monitoring of the incorporation of chondroitin 
into the CA network resulting in the formation of CAD network.   
To prepare the P network, stock solutions of individual KWK and EWE 
peptides were diluted to 2.27 % mass fraction (16 mmol/L) with PBS buffer at pH 
7.4.  Diluted solutions of the peptide modules were centrifuged separately for 10 min 
at 8,000 rpm, and 200 µL of each KWK and EWE peptides were mixed through Y-
shaped connector in the sealed cell of rheometer, immediately followed by 
monitoring of the gelation process resulting in the P network.   
The procedure for CAP network preparation was similar to the steps used for 
CAD networks described above.  Stock solutions of chitosan and alginate were 
diluted to 1 % mass fraction, and 100 L of each solution were mixed together in the 
sealed cell of the rheometer using a Y-shaped connector.  After 2 hrs of equilibration 
(necessary to mature the CA network), pH of the network was measured and adjusted 
to 7.4 by addition of very small volumes (several L) of concentrated NH4OH 
solution.  Then, 100 L of each 4.54 % mass fraction (32 mmol/L) KWK and EWE 
peptides solution were mixed with the matured chitosan/alginate network.  
Rheological measurements of gelation kinetics were started immediately.   




diluted to 1.33 % mass fraction by PBS and 75 µL of each solution were mixed in the 
sealed cell of the rheometer using a Y-shaped connector.  The resulting mixture was 
equilibrated for 2 hrs (to get mature CA network), then 50 µL of chondroitin solution 
diluted to 0.64 % mass fraction by PBS was added, and the sample was equilibrated 
for another 10-12 hrs (time necessary for maturation of CAD network estimated from 
the rheology experiments for CAD network). Then, 100 L of each 4.54 % mass 
fraction (32 mmol/L) KWK and EWE peptides solution were mixed with the 
matured chitosan+alginate+chondroitin network.  Rheological measurements of 
gelation kinetics were started immediately. 
In all samples final concentrations for components in each sample were (in % 
mass fraction): chitosan (0.25 %), alginate (0.25 %), chondroitin (0.076 %), two 
peptide modules together (2.25 % or 16 mmol/L).  During the equilibration 
procedures, mixtures in the sealed cell were covered with parafilm to prevent sample 
drying. 
3.3.4 Dynamic Rheometry Measurements 
Dynamic rheological measurements were performed using a NOVA 
Rheometer (REOLOGICA Instruments, Inc., Sweden) featuring a null balance system 
which allows for nano-torque and nano-strain measurement control and analysis. The 
instrument is also equipped with a sealed-cell geometry which prevents dehydration 
of the water-based samples during prolonged measurements. In addition, to exclude 
possible dehydration of the sample at 25 °C, a simple in-house designed system was 




characterizations of the samples were performed using a 25 mm diameter cone-and-
plate steel geometry.  
Time-sweep measurements were conducted at 0.2 % strain amplitude and 1 
rad/s angular frequency. The data points were taken once every 180 s after two 
integrations with 5 s delay time, between the start of application of the respective 
stress and the start of data acquisition for calculations. This delay is necessary for 
equilibration of the plate before the torque measurement.  
After the time-sweep measurements, frequency-sweep measurements were 
conducted at the respective temperatures with 0.2 % strain amplitude, while the 
frequency was varied from 0.01 to 100 rad/s in a log mode with 18 data points per 
frequency decade. In the frequency-sweep experiment, the number of integration 
cycles, Nc, was varied from 1 to 500. The greater number of integration cycles 
corresponds to higher frequency values. Nc ≈ 1 + 500 × (ωi/ωmax), where ωi is the 
angular frequency of the i-th measurement, ωmax is the maximum angular frequency, 
and here ωmax = 100 rad/s. The delay time between the start of application of the 
respective frequency and stress and the start of data acquisition for calculations was 
varied from 65 s to 5 s, in reciprocal proportion to the frequency.  
After the frequency-sweep measurements and before the strain-sweep 
measurements, a time-sweep of 3 hr was performed on the gel at 0.2 % strain 
amplitude, 1 rad/s frequency to confirm that the gel remains undisturbed by the 
frequency-sweep (see Appendix figures A13-A17). Strain-sweep measurements were 




of strain amplitudes from 0.1 % to 100 % in a log mode with 23 data points per 
decade. 
 
3.3.5 SANS Sample Preparation 
The conditions and procedures for the preparation of the networks for SANS 
studies were described in the details above for the dynamic rheology. All samples 
were made inside titanium cells with 1-mm path lengths and quartz windows 30 mm 
in diameter, which are routinely used for SANS measurements at the National 
Institute of Standards and Technology (NIST) Center for Neutron Research (NCNR).  
For the mixed oligopeptide-polysaccharide networks, the preparation steps and time 





component were exactly the same as described above for rheological experiments.  
Since no kinetic measurements were performed using SANS, all samples were 
prepared at least 72 hrs before the measurements (time necessary to make CAP 
and/or CADP networks was estimated from the rheology experiments). 
3.3.6 SANS Structural Analysis 
Sample structures were elucidated using the same SANS instrument as 
described in chapter 2 of this dissertation. Also, the correlation length and fractal 
analysis were performed using the same techniques described in chapter 2.  
In addition to previously described techniques, we used a simulated annealing 
algorithm which follows the common approach used for 3D dummy atom shape 
restoration of the scattering particle (102). However, we implemented the algorithm 
in a purpose-written program that is described elsewhere (103),
 




average cross-sectional shape of the fibers under study.  In all these calculations, the 
dummy atoms were arranged on a flat grid of 50  100 close-packed dummy atoms.  
The size of each atom was 5 Å.  The program calculated the pair distance or vector 
length distribution function, Pc(r), for the model cross-section composed of the 
dummy atoms.  Pc(r) is the distribution of distances between area elements in the 
cross section, weighted by the scattering density at each radial value, r. The Fourier 
transformation of Pc(r) yields the model scattering profile for cross-section QImod(Q).  
In the optimization procedure, the program minimized the discrepancy between the 
model scattering data Imod(Q) and the experimental scattering data Iexp(Q) (53).  After 
optimization, values for zero-angle scattering intensity Ic(0), the area of the cross-
section Sc, maximum cross-sectional dimension Dmax, and the radius of gyration of the 
cross-section Rc, were determined from Pc(r); Dmax was the r value at which Pc(r) 
goes to 0. The zero
th
 and the second moments of Pc(r) yield Ic(0) and Rc values, 
respectively.  The radius of gyration of the cross-section Rc was the contrast-weighted 
mean distance of all area elements from the center of scattering density.  The program 
also outputs the model cross-sections as atomic coordinate files in the Protein Data 
Bank format which allowed their pictorial presentation.  These cross-sections are 
representative of average cross-sections within each sample type. The solutions are 
unique and characterized by low Chi-squared values (χ
2
 ~ 1.0 - 1.1). χ
2
 values less 
than 2 give acceptable fitting for this model, where χ
2
 calculations were described in 
detail (103). Corrections for scaling and incoherent background were applied to the 
model scattering profile so it could be compared directly with experimental scattering 




We have also explored the three-dimensional morphology of mixed 
oligopeptide-polysaccharide hydrogels using the program SAXSMorph (104).  2D 
slices of the hydrogel bulks created by SAXSMorph were then analyzed using the 
NIH image analysis program ImageJ (see Appendix figure A18) (105). 
3.4 Results 
3.4.1 Mechanical Properties of Oligopeptide-Polysaccharide Hydrogels 
Time-sweep rheological monitoring of the gelation kinetics of CA (Figure 3.1(A)) 
showed that pairing of positively charged chitosan and negatively charged alginate 
resulted in a very weak material with an elastic modulus G' value of only ~ 100 Pa.  
While the viscous modulus G'' was lower than G', the value of the phase angle  was 
still only around 30°, which is indicative of a weak hydrogel network.  The frequency 
spectrum (Figure 3.1(B)) suggests that the CA hydrogel is rather mobile showing 
strong growth in G' at higher frequencies due to relaxation, with an evident maximum 
of G'' at frequencies around 20 rad/sec.  At the same time, the fibrous network formed 
by the CA did not show the signs of break, up to 100 % strain ( ) (Figure 3.1(C)).  
Addition of chrondroitin to CA resulted in the incorporation of chondroitin into the 
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Figure 3.1:  Dynamic oscillatory rheological characterization of CA. (A) Time-
sweep monitoring of gelation kinetics; plateau G' ~ 100 Pa; final δ ~ 30°.  (B) 
Frequency-sweep after viscoelastic modulus reached plateau, max G'' at ω ~ 20 
rad/sec.  (C) Strain-sweep performed after frequency-sweep; Elastic modulus G' 
(open circles); viscous modulus G'' (solid circles); shear modulus G (triangles). 
 
This is evident from further slow growth in the G' value, which within ~8–10 
hours plateaued at ~ 400 Pa (Figure 3.2(A)).  The resulting CAD hydrogel was 
characterized by a smaller phase angle as compared to CA (  ~ 9°).  However, the 
frequency spectrum of CAD was very similar to that of CA and is also characteristic 
of a mobile gel where G' is growing at higher frequencies due to relaxation, and a 
maximum G'' observed around 90 rad/sec (Figure 3.2(B)).  Unlike CA, in strain-




3.1(C) and Figure 3.2(C)).  Yet, CAD was very elastic and retained a low phase angle 
value (  ~ 12°) up to  ~ 100 % (Figure 3.2(C)). 
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Figure 3.2:  Dynamic oscillatory rheological characterization of CAD. (A) Time-
sweep monitoring of gelation kinetics after addition of chondroitin to CAD network; 
plateau G' ~ 400 Pa; final δ ~ 9°.  (B) Frequency-sweep after viscoelastic modulus 
reached plateau, max G'' at ω ~ 90 rad/sec.  (C) Strain-sweep performed after 
frequency-sweep; Elastic modulus G' (open circles); viscous modulus G'' (solid 
circles); shear modulus G (triangles). 
 
Gelation of the peptide pair KWK+EWE continued for ~ 48 hours after 
mixing and resulted in a fairly stiff hydrogel P with a plateau G' ~ 90 kPa (Figure 
3.3(A)).  As opposed to both polysaccharide networks CA and CAD, peptide 
hydrogel P formed a very stable, solid-like material.  The observed log 
G′(ω) and G″(ω) profiles showed a small dependence on the frequency within the 




a solid-like hydrogel network with little or no mobility at time scales up to t = 2π/ω ~ 
600 sec, i.e., up to the longest measurement duration (Figure 3.3(B)).  Also unlike CA 
and CAD, P was more brittle (yields at  ~3-4 %) and completely broke into a very 
inhomogeneous mass above  ~ 6 % (Figure 3.3(C)).  
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Figure 3.3:  Dynamic oscillatory rheological characterization of  P. (A) Time-sweep 
monitoring of gelation kinetics; plateau G' ~ 90 kPa.  (B) Frequency-sweep after 
viscoelastic modulus reached plateau.  (C) Strain-sweep performed after frequency-
sweep; yield strain value  ~ 3-4 %; complete break of hydrogel at  ~ 6 %.  Elastic 
modulus G' (open circles); viscous modulus G'' (solid circles); shear modulus G 
(triangles). 
 
In order to incorporate the oligopeptide fibers into the polysaccharide 
networks, we conducted the gelation process by mixing individual peptide modules 
KWK and EWE with an already existing CA network.  Interaction of charged 




moduli, which in 72 hrs after adding of KWK and EWE results in a plateau G' ~ 10 
kPa (Figure 3.4(A)).  The resulting composite CAP gel was significantly less stiff as 
compared to the pure peptide network P (cf. Figure 3.3(A)), and showed a slightly 
high phase angle,  ~ 17°.  However, mutually attractive KWK and EWE 
incorporated into the CA gel markedly stabilized the assembled CAP network. The 
frequency sweep (Figure 3.4(B)) was characteristic of a stable, solid-like material.  
Similarly to the P gel (cf. Figure 3.3(B)), CAP showed little mobility up to 600 sec.  
Unlike the P gel, the presence of CA fibers within the peptide hydrogel network 
improved the strain resistance of CAP (Figure 3.4(C)) and made it virtually 
unbreakable. Even at the highest strain value (  ~ 100 %),   still remained around 25-
30° (< 45°).  
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Figure 3.4:  Dynamic oscillatory rheological characterization of CAP. (A) Time-
sweep monitoring of gelation kinetics; plateau G' ~ 10 kPa; final δ ~ 17°.  (B) 




performed after frequency-sweep; retaining δ ~ 25-30° even at strain values  ~ 100 
%.  Elastic modulus G' (open circles); viscous modulus G'' (solid circles); shear 
modulus G (triangles). 
 
The elastic behavior in the composite oligopeptide-polysaccharide hydrogels 
became even more evident when oppositely charged KWK and EWE peptides co-
assembled within the already matured CAD network.  After 72 hrs of gelation, the 
resulting CADP hydrogel reached the same plateau value of elastic modulus (G' ~ 10 
kPa) as was observed in the case of CAP hydrogel (cf. Figure 3.5(A) and Figure 
3.4(A)).  However, unlike CAP, CADP demonstrated more profound solid-like 
behavior characterized by a rather low phase angle,  ~ 5°.  The frequency sweep for 
CADP was similar to that of P and CAP (cf. Figure 3.5(B), Figure 3.3(B), and Figure 
3.4(B)) and points to the formation of a very stable, immobile hydrogel.  Also, the 
presence of polysaccharides in CADP hydrogel improved the resistance of CADP to 
deformation.  The strain sweep (similar to P) became non-linear at  ~3-4 %, 
however, CADP was much less brittle and broke only around  ~20 % (cf. Figure 
3.5(C) and Figure 3.4(C)).  At the same time, CADP showed somewhat greater 
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Figure 3.5:  Dynamic oscillatory rheological characterization of CADP. (A) Time-
sweep monitoring of gelation kinetics; plateau G' ~ 10 kPa; final δ ~ 17°.  (B) 
Frequency-sweep after viscoelastic modulus reached plateau.  (C) Strain-sweep 
performed after frequency-sweep and 3 hrs of equilibrating time-sweep (see, 
Materials and Methods); yield value  ~ 3-4 %; complete break of hydrogel at  ~ 6 
%.  Elastic modulus G' (open circles); viscous modulus G'' (solid circles); shear 
modulus G (triangles). 
 
 In summary, the above observations show that incorporation of peptides into 
the already existing fibrous networks of polysaccharides results in less stiff hydrogels 
(characterized by lower elastic moduli) as compared to the pure peptide network.  On 
the other hand, the oligopeptide-polysaccharide composite hydrogels CAP and 




unbreakable up to ~ 100 % strain and are far less brittle as compared to the stiffer 
peptide hydrogel P.  The difference in mechanical properties detected for the 
oligopeptide-polysaccharide composite hydrogels CAP and CADP as compared to 
the peptide hydrogel P could be explained by the interactions of oligopeptides with 
polysaccharides.  Indeed, it has been shown that oligopeptides are capable of forming 
complexes with polysaccharides. Such complexation with polysaccharides could 
efficiently interfere with the attraction of oppositely charged KWK and EWE and 
hinder their co-assembly and packing into the fibers. This interference could lead to 
much less stiff CAP and CADP hydrogels as compared to P. 
 
3.4.2 Structural Analysis of Oligopeptide-Polysaccharide Hydrogels Using SANS 
The analysis of structural characteristics of the hydrogels using SANS was 
employed to explore the relationships between the structural characteristics of the 
fibrous networks at the nanoscale level and the mechanical properties of bulk material 
formed by such networks. 
In the SANS experiments, all five hydrogel networks, CA, CAD, P, CAP and 
CADP,  showed an increased scattering intensity consistent with the formation of 
large assemblies (Figure 3.6).  It can be seen in Figure 3.6 that the composite 
oligopeptide-polysaccharide hydrogels CAP and CADP (as well as the pure peptide 
hydrogel P) show much greater scattering intensities as compared to pure 
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Figure 3.6:  SANS scattering profiles I(Q) vs. Q for polysaccharide and mixed 
oligopeptide-polysaccharide networks: CA (chitosan + alginate), red; CAD (CA + 
chondroitin), green; P (KWK + EWE), purple; CAP (CA + P), black; CADP (CAD + 
P), blue.  Guinier plots for rod-like particles, lnQ*I(Q) vs. Q
2
, are shown in the inset, 
and the linearity in this region indicates the formation of elongated fibers in all 
systems.  Color code on inset corresponds to the main figure.  Statistical error bars 
correspond to one standard deviation and represent error in the scattering intensity 
estimation.  Error bars are large at the instrument configuration overlap region but are 
smaller than the plotting symbols at low Q. 
 
Since the scattering intensity profile I(Q) vs. Q reflects the mass and/or volume of the 
scattering assemblies, this points to the formation of denser, higher scattering 
aggregates for P, CAP, and CADP consistent with greater stiffness of these 
hydrogels observed in dynamic rheology experiments (see, Table 3.1, and also cf. 
Figure 3.1–Figure 3.5).  One might expect that in addition to the density of the fibrous 
network, the morphology of the individual fiber and its cross-section also influences 




modeling routine (103), we have restored the cross-sectional shapes of the fibers 
constituting the networks under study with the best fit of scattering data (χ
2 
< 1.5). 
The cross-sectional shapes represent average cross-sections within each sample type. 
We have also derived the associated pair-wise distance distribution functions of the 
cross-sections, Pc(r).  From the Pc(r) function, the important dimensional parameters 
of the fiber cross-section were derived such as the maximum cross-sectional 
dimensions of the fiber, Dmax, and the radius of gyration of the cross-section, Rc 
(Table 3.1).  
 
Figure 3.7:  Pictorial description of the 2D shapes of a fiber cross-section in 
polysaccharide and composite oligopeptide-polysaccharide networks.  The addition of 
chondroitin D to CA (chitosan + alginate, red) leads to much bigger and thicker fiber 
CAD (CA + chondroitin, green); while the addition of the peptides P (KWK + EWE, 
purple) to the above polysaccharide networks with the formation of CAP (CA + P, 
black) or CADP (CAD + P, blue) completely disrupts the structures of 
polysaccharides and results in the fibers with the cross-section very similar to the 
pure peptide network P.  
 
It can be seen from the fiber cross-sections in Figure 3.7 that the addition of 





into the fiber structure. As a result, the average cross-section of the resulting fiber of 
CAD is bigger and thicker.  As compared to CA, the maximum dimension of CAD, 
Dmax, increased from 445 Å to 495 Å, and the radius of gyration of the cross-section 
Rc grew from ~153 Å to ~170Å (Table 3.1).  Incorporation of D into the CA fiber 
structure is also evident from the changes observed in the Pc(r) function of the cross-
section (Figure 3.8(A)). Here, the addition of D results in a significant increase in 
contributions from the higher vector lengths scales ~400 Å.  This is consistent with 
the formation of bigger and thicker fibers evident from the growth in Dmax and Rc 
when CA is transformed to CAD.  One might suggest that this increase in thickness is 
translated into the greater stiffness of the CAD network as compared to the CA 
network (G  of CAD is 4-fold larger than G  of CA; see Table 3.1, also cf. Figure 3.1 
and Figure 3.2). 
The individual fiber of the pure peptide hydrogel P, co-assembled from KWK 
and EWE peptide modules, has a much smaller average cross-section (Figure 3.7) 
with a Pc(r) pattern characteristic of highly asymmetrical flattened shapes (Figure 
3.8(B)).  Accordingly, the Dmax and Rc values of the P hydrogel are significantly 
lower as compared to CA and/or CAD networks (Table 3.1).  However, despite 
smaller dimensional characteristics, the stiffness of the pure peptide hydrogel P is 
more than ~200-fold greater as compared to pure polysaccharide networks CA and 
CAD (Table 3.1, cf. Figure 3.1–Figure 3.3).   
In this context, the cross-section dimensional parameters of the individual 
fiber are by no means the only determinants of the mechanical properties for the bulk 




the network density, packing and compactness of the fiber, which reflects its rigidity.  
SANS analysis allows us to reliably determine the correlation length of the network 
Lc or its mesh size, which is an extremely sensitive measure of the network density 
and, thus, of its strength.  Even a moderate difference in  
 




















   






























Figure 3.8:  Changes in the pair-wise distance distribution functions Pc(r) of the fiber 
cross-section observed during the formation of polysaccharide and composite 
oligopeptide-polysaccharide networks. (A) Transformation of the Pc(r) for the CA 
(chitosan + alginate, red) network after the addition of chondroitin D resulting in the 
formation of the intricate CAD (CA + chondroitin, green) network.  (B) Pc(r) as 
function of the pure peptide hydrogel P (purple) characterizing the flattened cross-
section of the individual fiber.  (C) Cross-section Pc(r) of the fibers assembled in the 
mixed hydrogels CAP (CA + P, black) and CADP (CAD + P, blue) after disruption of 
the fibers of CA and CAD. 
 
the correlation length might have significant repercussions on the bulk material 
properties.  For the materials described here, P is characterized by a more than 2-fold 




difference in Lc results in a much denser, solid network, which explains the profound 
strengthening in the elastic modulus G' of the P hydrogel (Table 3.1, cf. Figure 3.1–
Figure 3.3). Another factor contributing to bulk material properties is the mass-fractal 
dimension d, which describes the structure of the repetitive unit (“building brick”) of 
the fiber and the packing of such “building bricks” within the fiber.  Mass-fractal 
analysis shows that the pure polysaccharide networks, CA and CAD, are assembled 
from randomly-branched building bricks (d values from 2.7 to 3.0, Table 3.1). These 
materials are characterized by a much greater degree of swollenness as opposed to the 
Gaussian-coil building bricks (d ~ 1.6, Table 3.1) characteristic for the pure peptide 
hydrogel P.  Evidently, the fibers of P are assembled from more tightly packed 
repetitive units than the CA and/or CAD, which may be why they are characterized 
by much greater elastic modulus values (Table 3.1).  Based on the above analysis, 
when comparing such structurally dissimilar networks—pure polysaccharides vs. pure 
peptides—the correlation lengths of the networks as well as the packing and 
compactness of the fibers define the mechanical strength of the bulk material to a far 
greater degree than the dimensional characteristics of the individual fiber. 
In the same vein, one could analyze the formation of the composite 
oligopeptide-polysaccharide networks CAP and/or CADP.  As seen from Figure 3.7 
and Figure 3.8(C), addition of the peptide component P (KWK and EWE modules) 
to the matured polysaccharide networks, results in complete disruption of the intricate 
structural characteristics of CA and CAD.  2D shapes of the average cross-sections 
(Figure 3.7) and Pc(r) functions of CAP and CADP (Figure 3.8(C)) have a distinctive 




peptide hydrogel P.  This observation confirms the above conclusion made on the 
basis of dynamic rheology data that during the co-assembly, whereby the charged 
peptide modules interact with the CA and/or CAD networks.  Despite evident 
structural similarity of the fiber cross-sections of the P, CAP, and CADP networks, 
the correlation length Lc of the composite oligopeptide-polysaccharide hydrogels is 
significantly greater than in the case of the pure peptide hydrogel P (Table 3.1). 
Therefore, the mechanical strength of the composite oligopeptide-polysaccharide 
hydrogels is significantly lower as compared to the pure peptide network P (Table 
3.1, Figure 3.3–Figure 3.5). 
Table 3.1:  Dimensional characteristics of the hydrogel networks and structural data 
of the individual fibers from SANS data analysis, and their elastic moduli from 
dynamic rheometry experiments.  
Hydrogels Dmax (Å) Rc (Å) Lc (Å) d B G' (Pa) 
CA (chitosan + alginate)  445 152.7 150 3.0 ± 0.2 5.2×10
-4
 100 
CAD (CA + chondroitin) 495 170.2 155 2.7 ± 0.1 3.7×10
-4
 400 
P (L-KWK + L-EWE) 160 40.6 60 1.6 ± 0.2 4.1×10
-3
 90,000 
CAP (CA + P)  100 25.7 98 1.7 ± 0.2 4.4×10
-3
 10,000 
CADP (CAD + P) 145 39.0 104 1.9 ± 0.2 4.0×10
-3
 10,000 
Dmax is the max dimension of the fiber cross-section in Å; Rc is the radius of gyration 
of the cross-section of the individual fiber in Å; Lc is the correlation length reflecting 
the mesh size of the network; d is the mass-fractal dimension defining the repetitive 
unit of the fiber (its “building brick”); B is the mass-fractal power-law prefactor 
describing the dimensional characteristics of the repetitive unit; and G' is the elastic 
modulus of the networks in Pa. 
 
 
To summarize, the observed high scattering intensity is indicative of the 
interaction between polysaccharides and/or peptides, resulting in the formation of the 




induces complete disruption of the initial polysaccharide fibrous networks.  New 
oligopeptide-polysaccharide hydrogels are assembled and at the level of the 
individual fiber, such composite networks are structurally similar to the pure peptide 
hydrogel.  Significantly greater mesh sizes of these composite networks leads to 
much less stiff material as compared to the pure peptide hydrogel.  SANS analysis 
corroborates the suggestion made above on the basis of the rheology data that the 
weaker fibrous network of the composite oligopeptide-polysaccharide hydrogel is 
formed due to the complexation between peptide modules and sugar moieties, thus 
precluding the assembly of stronger, mutually reinforcing networks. 
3.5 Conclusions 
It is quite reasonable to expect that attempts to create biomaterials needed for 
human tissue engineering would be based on similar chemical composition of, e.g., 
cartilage, tendons, or ligaments which are formed from proteins and polysaccharides 
(glycosaminoglycans).  In the present chapter, we aimed to prepare composite 
hydrogels in which the fibrous peptide networks were combined with the fibers 
assembled from long, charged polysaccharide structures. In this way, our materials 
would mimic the chemical and/or structural composition of protein/polysaccharide 
composite-based human soft tissues.  The pure polysaccharide networks (CA and 
CAD) were very weak materials with low elastic moduli, however, with significant 
resistance to deformation.  Incorporation of the polysaccharides into the oligopeptide 
hydrogel also resulted in materials (CAP and CADP) with very high resistance to 
deformation (strain values from 20 % to 100 %), far less brittle compared to the pure 




with the polysaccharides may be responsible for the significant loss of stiffness of the 
composite material as compared to the pure peptide hydrogel. 2D shapes of the 
individual fiber cross-sections, changes in the dimensional characteristics of the fiber, 
and the mesh size of the network illustrate the aforementioned interaction between the 
peptides and sugars. These results also explain the weakening of the composite 
oligopeptide-polysaccharide material.  Our results suggest a novel approach for 
creating highly deformation-resistant biomaterials. Ways to increase material strength 





Chapter 4: Handedness Matters: Chirality in Biopolymer-Based 
Material Design 
4.1 Introduction 
In the human body, interactions between proteins and polysaccharides are 
extremely important and common. Proteins and polysaccharides can interact to form 
complex structures with various mechanical and structural properties. The 
extracellular matrix, for example, is an interlocking mesh of proteins and 
glycosaminoglycans (GAGs). It is well known that these proteins and polysaccharides 
are made from chiral components. In fact, proteins and polysaccharides are made 
from components with opposite chirality; proteins are made only from L-amino acids 
and most polysaccharides are made from D-sugars. 
 Recently, the mechanical and structural properties of gels formed from pairs 
of oppositely charged, self-repulsive undecapeptides were characterized and both L- 
and D- forms of the peptides were made (49). Both the L-gel (made from two L-
peptide modules) and the D-gel (made from two D-peptide modules) were 
mechanically and structurally identical, while mixed chirality peptide gels were much 
weaker. This result suggested that peptide homochirality had a mechanical advantage. 
It is known that the natural amino acid/sugar (L-amino acids/D-sugars) combination 
confers molecular advantages. For example, L-enzymes recognize L-peptides and D-
nucleic acids but not D-peptides and L-nucleic acids (107, 108). This phenomenon is 
known as chiral selectivity. What remains unclear is whether the (L-amino acids, D-




Based on these differences in molecular recognition, we hypothesized that the 
introduction of a polysaccharide would disrupt the structural and mechanical 
degeneracy of the mirror-image peptide hydrogels due to polysaccharide chiral 
selectivity. 
In order to study the mechanical and structural implications of interactions 
between proteins and polysaccharides, we focused on five systems: peptide hydrogels 
(D or L) and the D-saccharides; β-cyclodextrin (βCD), chondroitin (Chd), glycogen 
(Glyn) and hydroxypropyl cellulose (HPC). The peptide hydrogels, synthesized using 
either L- or D-amino acids, act as model systems for proteins in the extracellular 
matrix, creating mechanically rigid and complex networks. Each peptide module 
contains two tryptophans (Trp), which have been shown to interact weakly with sugar 
molecules (109-111). It has been reported that βCD, a cyclic oligosaccharide, 
interacts more strongly with L-Trp than D-Trp (112). From a biomaterials standpoint, 
our interest was in whether this selectivity could be seen with D-βCD and other 
saccharides in the context of gelation properties like mechanical stiffness and gelation 
kinetics. Saccharides with a range of properties were chosen to represent the different 
types present in the body. βCD was chosen because of its demonstrated chiral 
selectivity with Trp in solution and well-defined structure. Chondroitin was chosen 
for its charge and natural prevalence in cartilage. Glycogen was chosen for its 
branched design and ubiquitous presence in muscle tissue. HPC was chosen because 
it was linear, neutral and water soluble.  In this way, effects of saccharide properties 




 In this work, the effects of chiral selectivity on the bulk mechanical and 
structural properties of biopolymer based materials were described using rheology 
and small-angle x-ray scattering (SAXS) respectively. This approach can provide 
insight on using chirality as another tool for tuning the properties of biopolymer-
based biomaterials. In addition, it may give insight from a mechanical standpoint for 
why proteins and saccharides have opposite chirality in nature. 
4.2 Materials and Methods 
4.2.1 Materials 
β cyclodextrin (1.14 kDa, Sigma-Aldrich), glycogen (100-1000 kDa, Sigma-
Aldrich), bovine chondroitin sulfate sodium salt (~20 kDa, Pfaltz & Bauer) and 
hydroxypropyl cellulose (~80 kDa, Sigma-Aldrich) were used as purchased. 
4.2.2 Peptide Synthesis and Preparation 





 (E-peptide) were made with L-amino acids and D
+
 (K-peptide) and 
D
-
 (E-peptide) were made with D-amino acids. The purity and the molecular weight 
of each purified peptide were verified by reverse-phase analytical HPLC and mass 
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Each purified peptide sample was dissolved in ultrapure water and dialyzed at 
room temperature against water for 24 hours using a dialysis membrane with a 
molecular weight cutoff of 100-500 Da. The concentration of each peptide sample 
was determined on the basis of the UV absorption of the Trp residues in each peptide, 




 at 280 nm (101). 
4.2.3 Dynamic Rheometry Sample Preparation and Characterization 
For peptide+Chd sample solutions, peptide concentrations were adjusted to 32 
mM and E-peptides were mixed 1:1 with 20 mg/mL chondroitin in PBS buffer while 
K-peptides were mixed 1:1 with PBS buffer, to avoid electrostatic interactions 
between K-peptides and chondroitin before peptide mixing. For 4 mM peptide+βCD 
sample solutions, both E- and K-peptide concentrations were adjusted to 16 mM and 
mixed 1:1 with 4 mM βCD in PBS buffer. For 8 mM peptide+βCD sample solutions, 
both E- and K-peptide concentrations were adjusted to 32 mM and mixed 1:1 with 8 
mM βCD in PBS buffer. For peptide+Glyn sample solutions, both E- and K-peptide 
concentrations were adjusted to 32mM and were mixed 1:1 with 10 mg/mL glycogen 
in PBS buffer. For 2 mM peptide+HPC sample solutions, both E- and K-peptide 
concentrations were adjusted to 8 mM and were mixed 1:1 with 1.25 mg/mL HPC in 
PBS buffer. For 8 mM peptide+HPC sample solutions, both E- and K-peptide 
concentrations were adjusted to 32 mM and were mixed 1:1 with 1.25 mg/mL HPC in 
PBS buffer. The ionic strengths of the samples were tuned to the conductivity of PBS 
buffer using a conductivity meter. Sample preparation procedures and measurements 




To make each gel, solutions of two oppositely charged, same chirality peptide 
modules containing saccharides were centrifuged separately for 10 min at 8,000 rpm. 
200 μL of each K- and E-peptides with saccharides were mixed through a Y-shaped 
connector in the sealed cell of the rheometer, immediately followed by monitoring of 
the gelation process. 
Dynamic rheological measurements were made using a sealed-cell NOVA 
rheometer (ATS REOLOGICA Instruments Inc., Sweden) equipped with a 
temperature-control unit, a custom-made humidifier and a 25-mm diameter cone-and-
plate stainless steel geometry (4˚ cone angle). All experiments were conducted at 
25˚C. The detailed description of the sequential rheological experiments can be found 
in Chapter 3. Briefly, time-sweep measurements were conducted at 0.2% strain 
amplitude and 1 rad/s angular frequency. Time-sweep measurements were 
immediately followed by frequency-sweep measurements, which were performed at 
0.2% strain amplitude from 0.01 to 100 rad/s. Strain-sweep measurements were then 
performed with one integration cycle at 1 rad/s frequency, with a strain amplitude 
range from 0.1 % to 100 %. 
4.2.4 SAXS Sample Preparation and Data Collection 
Glyn+peptide, HPC+peptide and βCD+peptide solutions were prepared for 
SAXS as described for dynamic rheometery experiments. Gels were prepared for 
SAXS experiments as described previously (49). Briefly, 10-15 μL equal volumes of 
each peptide (10-15 μL) were centrifuged (20 sec at 500 RPM) into a cylindrical glass 




mm. Scattering data were collected at 0.5, 1.5, 3, 5, 7, 24, 48, and 72 hrs after mixing 
for Glyn+peptide, HPC+peptide and βCD+peptide samples. 
Structures of the gels were investigated using the SAXS beamline 12ID-B of 
the Advanced Photon Sources (APS) at the Argonne National Laboratory. For every 
measurement, the monochromic X-ray beam (λ = 0.689 Å) with a size of 0.07 mm × 
0.20 mm was adjusted to pass through the centers of the capillaries. In order to avoid 
detector saturation and radiation damage to the samples, the exposure time for all 
samples was set to 0.5 sec. The 2D detector Pilatus 2M (DECTRIS Ltd) was used to 
collect X-ray scattering intensities. 
4.2.5 SAXS Data Analysis 
The 2D scattering images were converted into 1D scattering profiles of I(Q) 
vs. Q in the Q-range from 0.007 Å
-1
 to 0.6 Å
-1
 by means of azimuthal averaging after 
solid angle correction. Using the software package at the beamline 12ID-B, the 
resulting 1D profiles were normalized over the intensity of the transmitted X-ray 
beam. I(Q) is the scattering intensity of X-rays, and Q is the scattering vector 
amplitude which is related to the X-ray wavelength λ and the scattering angle θ by 
    (4.1) 
Solvent scattering subtraction (PBS) involved normalization based on the ratio of 
incident and transmitted X-ray photon counts to account for the slight differences in 
the thickness of different capillaries. Also additional background scattering correction 




The length of the fibers exceeded the upper detection limits of SAXS (~ 
500Å) so we analyzed their scattering data in terms of the cross-sectional dimensions 
of the scattering particles. This was done by multiplying I(Q) values by Q, which 
essentially removes information about the length of the scattering particles (81). 
A simulated annealing algorithm was used to restore the 2D cross sections for 
the hydrogels. We modeled the 2D cross sections of the hydrogel fibers using the 
algorithm in a purpose-written program that is described elsewhere (103). A flat grid 
of 20 X 20 close-packed dummy atoms was arranged, each 3 Å in diameter. This 
technique allows one to model pictorial cross section slices of the hydrogels showing 
the fibers and how they are connected in the fibrous network. The program calculated 
the pair distance distribution function, Pc(r), for the model cross-section made of the 
dummy atoms. Pc(r) is the distribution of distances between area elements in the 
cross-section, weighted by the scattering density at each radial distance, r. The 
optimization procedure is in general described elsewhere (103,113). 
After optimization, the radius of gyration of the cross-section Rc (Å), the 
cross-section area Sc (Å) and the zero-angle scattering intensity Ic(0), which is 
proportional to the mass per unit length of the fiber (in arbitrary units per Å), were 
determined from Pc(r). The zero-th and the second moments of Pc(r) provide Ic(0) and 
Rc values, respectively. Rc is the contrast-weighted mean distance of all area elements 
from the center of scattering density.  
The annealing program also outputs the average model cross-sections as 
atomic coordinate files in Protein Data Bank format so they can become images. 2D 






 ~ 0.3-0.5). χ
2
 values were much lower for SAXS data here than for SANS data in 
Chapter 3 because there was some overlap in data collection using SANS. 2D 
network cross-sections (Figure 4.3) are pictorial representations of the networks and 
are not unique solutions. Based on these coordinates and the grid dimensions, the area 
of the cross-section, Sc, was calculated. Corrections for scaling and incoherent 
background were applied to the model scattering profile so it could be compared 
directly with experimental scattering data (103). 
 Persistence length analysis was performed using the IGOR 6.2/NIST NCNR 
Analysis Package. Persistence length, lp, is the length along the cylinder over which 
the flexible cylinder can be considered a rigid rod. Therefore, lp tells us about the 
stiffness of individual fibers. The model used in this analysis is a parameterization of 
simulations for a discrete representation of the Kratky and Porod worm-like chain 
model, applied in the pseudo continuous limit (114). Persistence length values given 
here are somewhat different from traditional values for the persistence lengths of 
polymer chains (where the fiber cross section must be smaller than the fiber 
persistence length). This is because our biopolymer fibers are self assembled by non-
covalent bonding, while polymer chains are covalently bound. Our biopolymer fibers 
are made from stacks of unit assemblies which, because they are non-covalently 
bound, can be shifted with respect to each other. As a result, the fiber cross-sections 
may be larger than fiber persistence length values. 
4.3 Results and Discussion 
 L/L+Glyn and D/D+Glyn gels gave very conclusive, consistent results in both 




D/D+Glyn. Time sweep results show that L/L+Glyn gelled faster and was stiffer than 
D/D+Glyn (Figure 4.1). Using SAXS to examine the underlying fiber structure of the 
two gels, we observed that L/L+Glyn fibers were significantly smaller in average 
cross-section as seen in both Figure 4.2 and the Sc values  in Table 4.1(L/L+Glyn was 
576 Å
2 
and D/D+Glyn  was 792 Å
2
). The lp for L/L+Glyn was also larger than 
D/D+Glyn, indicating the individual fibers in L/L+Glyn were stiffer than D/D+Glyn. 
Looking at an average cross-section of the fibrous network (slice of ~500 Å
 
x 500 Å) 
within the gels, it was apparent that L/L+Glyn networks were more closely packed, 
evidenced by the significantly lower correlation length when compared with 
D/D+Glyn networks (Table 4.1). Visually, the difference can be seen in Figure 4.3, 
where the L/L+Glyn network is distinctly more complex than D/D+Glyn, which also 
helps to explain the lower correlation length and higher persistence length. Taken 
together, the mechanical and structural results point to a stronger interaction between 
L-oligopeptides and glycogen, compared with D-oligopeptides and glycogen. 
Table 4.1: Structural data from SAXS analysis. The zero angle scattering intensity of 
the cross-section, proportional to mass per unit of fiber length (Ic(0)), radius of 
gyration of the cross-section (Rc), cross-section area (Sc), correlation length (lc) and 
persistence length (lp) were analyzed for oligopeptide+saccharide samples.  
Samples Ic(0) Rc (Å) Sc (Å
2
) lc (Å) lp (Å) 
8 mM L/L+Glyn 1.46E+05 12.41 576 39.5 26.0 
8 mM D/D+Glyn 2.80E+05 14.72 792 42.1 13.5 
2 mM L/L+HPC 6.19E+05 17.08 1170 72.4 11.9 
2 mM D/D+HPC 5.53E+05 17.34 1107 79.8 13.4 
4 mM L/L+HPC 5.35E+05 17.33 1089 71.0 14.9 
4 mM D/D+HPC 5.44E+05 17.01 1098 68.5 12.9 
8 mM L/L+HPC 3.56E+05 15.70 891 75.9 13.3 
8 mM D/D+HPC 4.66E+05 16.69 1017 65.2 9.5 
4 mM L/L+βCD 2.08E+05 16.96 684 58.7 7.6 





Perhaps because HPC (~80 kDa) is a much smaller polysaccharide than 
glycogen (~500 kDa), using the same weight by volume ratio of HPC did not 
significantly split the mechanical degeneracy of LL and DD (L/L+HPC: 100 kPa and 
D/D+HPC: 120 kPa, a difference of less than 10%). For this reason, we decreased the 
oligopeptide concentration (from 8 mM to 2 mM) in an effort to alter the ratio of HPC 
to peptide and possibly slow down gelation. At a 2 mM oligopeptide concentration, 
we did observe a difference, where L/L+HPC was significantly stiffer than D/D+HPC 
(L/L+HPC was 11.5 kPa and D/D+HPC was 8 kPa, Figure 4.1).  
 
Figure 4.1: Rheological time sweep plots for each L/L and D/D pair: Peptide+HPC is 
2 mM peptide + 0.125% w/v HPC; Peptide+Chd is 8 mM peptide + 1% w/v 
chondroitin; Peptide is 8 mM peptide; Peptide+Glyn is 8 mM peptide + 1% w/v 
glycogen; Peptide+βCD is 4 mM peptide + 4 mM βCD. Blue represents L/L samples 





To understand this result from a structural standpoint, we examined 
oligopeptide+HPC gels at three different concentrations (of each peptide): 8 mM, 4 
mM and 2 mM, while keeping the HPC concentration the same (0.125% w/v). From 
the Pc(r) plots (Figure 4.2), there was a decrease in the max Pc(r) values for both 
L/L+HPC and D/D+HPC as the oligopeptide concentration increased, which may be 
due to the relative decrease in HPC concentration which has higher x-ray contrast. 
The decrease in area was much more significant for L/L+HPC as oligopeptide 
concentration increased, which likely indicates a greater incorporation of HPC into 
the L/L network, since free HPC scatters more than free peptides.  
 
Figure 4.2: Pc(r) plots with fiber cross-section images for each L/L and D/D pair. 
Blue represents L/L samples and orange represents D/D samples. HPC concentration 
for all peptide+HPC samples was 0.125% w/v. 
 
At the 8 mM oligopeptide concentration, L/L+HPC fiber network had a larger 
correlation length than D/D+HPC, but D/D+HPC fiber cross-sections were much 




each other, giving materials with very similar mechanical properties. What is 
apparent here from SAXS analysis is that HPC is being incorporated very differently 
by L/L and D/D, solidifying the idea that chiral selectivity does occur at the 
macromolecular level. At the 2 mM oligopeptide concentration, cross-section size and 
fiber stiffness were very similar in both L/L+HPC and D/D+HPC, but the L/L+HPC 
correlation length was smaller than the D/D+HPC correlation length. This means the 
fibers of L/L+HPC are more closely packed, which is why L/L+HPC is a stiffer 
material than D/D+HPC at 2 mM. Using two-phase analysis, we will to try to further 
understand these concentration dependent network properties. Two-phase analysis is 
a method which allows for each component to be visualized within the structure, 
meaning that saccharides and oligopeptides could be seen as separate components. 
This is possible because oligopeptides and saccharides have different x-ray contrasts. 
 
 
Figure 4.3: Cross-sections of the hydrogel fibrous networks (slices ~500 Å
 
x 500 Å) 






 Mechanical strength results for βCD were quite similar to those for HPC. At 
an 8 mM oligopeptide concentration, the gelation kinetics and plateau G' values for 
L/L+βCD and D/D+βCD were very similar. As a result, we decreased the 
concentration of oligopeptide to 4 mM and we observed that L/L+βCD gelled faster 
and was stiffer than D/D+βCD. Unfortunately, SAXS data was only collected for 8 
mM oligopeptides with βCD. Structural data was in good agreement with mechanical 
results, mainly that both fiber and network structural properties were very similar. 
One exception was the difference between L/L+βCD and D/D+βCD correlation 
lengths, which was significant. This difference may have been due to differences in 
L-Trp interactions with βCD and D-Trp interactions with βCD, which have been seen 
by others on the molecular level (112). Though this difference is significant, it may 
not have affected mechanical properties because all other structural properties were 
similar. SAXS measurements of βCD with lower concentration oligopeptides, 
combined with two-phase analysis will likely elucidate this result. 
 For the final polysaccharide, chondroitin, only mechanical results have been 
collected. Much like glycogen, L/L+Chd and D/D+Chd had very different mechanical 
properties at an 8 mM oligopeptide concentration (Figure 4.1). Though the final 
stiffness of the two gels was similar, the gelation kinetics were significantly different. 
L/L+Chd gelation was much faster than D/D+Chd gelation. Since chondroitin is a 
charged polysaccharide, it adds another level of complexity (electrostatic interactions) 
to the oligopeptide-saccharide interactions because the oligopeptides are also charged. 







In this work, we studied the mechanical and structural properties of L/L and 
D/D oligopeptide hydrogels doped with four different D-saccharide types. Each 
polysaccharide type was able to split the mechanical degeneracy of L/L and D/D gels, 
though often not at all oligopeptide concentrations. In all cases where splitting 
occurred, L/L gels gelled faster and/or were stiffer than D/D gels. This provides a 
mechanical motivation for the biohomochirality combination to be (L-amino acids, D-
sugars) instead of the alternate combination (D-amino acids, D-sugars). Clearly, 
stronger interactions occur between L-oligopeptides and D-saccharides, regardless of 
saccharide size, shape or charge. Structural analysis corroborated these findings using 
a combination of techniques to examine the gels at the level of the fiber and the level 
of the network. Further structural studies will help to further clarify some of the 
results. These results have implications for future composite oligopeptide-






Chapter 5:  Enhancing Biocompatibility in D-Oligopeptide 
Hydrogels by Negative Charges 
 
5.1 Abstract 
Oligopeptide hydrogels are emerging as useful matrices for cell culture with 
commercial products on the market, but L-oligopeptides are labile to proteases.  An 
obvious solution is to create D-oligopeptide hydrogels, which lack enzymatic 
recognition.  However, D-oligopeptide matrices do not support cell growth as well as 
L-oligopeptide matrices.  In addition to chiral interactions, many cellular activities are 
strongly governed by charge-charge interactions.  In this work the effects of chirality 
and charge on human mesenchymal stem cell (hMSC) behavior were studied using 
hydrogels assembled from oppositely charged oligopeptides.  It was found that 
negative charges significantly improved hMSC attachment and proliferation in D-
oligopeptide gels but had little effect on their interactions with L-oligopeptide gels.  
This result points to the possibility of using charge and other factors to engineer 
biomaterials whose chirality is distinct from that of natural biomaterials, but whose 
performance is close to that of natural biomaterials. 
5.2 Introduction 
Biohomochirality is recognized as a defining feature of life on earth. It is well 
known that biomacromolecules are homochiral, where proteins contain exclusively L-
amino acids, and nucleic acids and most polysaccharides contain exclusively D-




extensively(115-118), its material aspect has been seldom explored.  In a previous 
work, we investigated how chirality affects the mechanical and structural properties 
of oligopeptide hydrogels (49). In this work, we explored how chirality impacts 
hydrogel-cell interactions and how such interactions are modulated by the charge 
status of the hydrogel. 
Hydrogels are viscoelastic materials with natural (e.g., the extracellular 
matrix) and manmade (e.g., contact lenses) examples.  As a result of the 
homochirality of its constitutive biopolymers, natural hydrogels are also homochiral.  
For example, the extracellular matrix (ECM) is a chiral material made of homochiral 





) hydrogels have been used to mimic the ECM for 
cell culture applications.  Considering that the ECM has a profound impact on cell 
growth (119) and differentiation (120), the question of how ECM chirality affects cell 
behavior has significant implications for biology and bioengineering.  In this work, 
oligopeptide hydrogels of different chirality makeups (homochiral, heterochiral and 
racemic) were used as ECM mimetics to grow cells.  The impact of chirality on cell 
attachment and proliferation was investigated.    
In addition to chiral interactions, many cellular activities are strongly 
governed by charge-charge interactions.  Examples include cell communication and 
ion transport across the cell membrane.  Regarding material-cell interactions, it has 
been found that both the type and the material charge density affect cell behaviors 
(121-124). Dadsetan et al. found that chondrocytes proliferated more on 




than positively charged monomers and that the percentage of monomer modification 
also affected cell behavior (122).  In fact, material surface charge can be used to 
modify cell behavior (125-127). Keselowsky et al. found that on positively charged 
surfaces, osteoblasts up-regulated osteoblast-specific gene expression, alkaline 
phosphatase enzymatic activity, and matrix mineralization compared with negatively 
charged surfaces (127). Based on these previous studies, we hypothesized that it 
might be possible to exploit charge to modulate chiral effects in hydrogel-cell 
interactions.  If proven true, then the combination of chirality and charge could be a 
powerful tool to guide cell behavior using oligopeptide hydrogels. 
In contrast to other chirality studies in which thin films were used (128,129), 
we used soft hydrogels which more closely resemble the ECM. The hydrogels used in 
this study were assembled from self-repulsive but mutually attractive oligopeptide 
modules (97). Gelation requires at least two oppositely charged modules.  This co-
assembling approach allowed us to systematically explore various chirality-charge 
combinations, some of which are not available to hydrogels based on the self-
assembly of a single oligopeptide.  
In this study, human mesenchymal stem cells (hMSCs) were used because 
they are extremely attractive candidates for cellular therapy. MSCs have many 
attributes including ease of isolation, high expansion potential and genetic stability 
(130). Further, MSCs can be used allogeneically, an important clinical advantage 
(131).
 
Understanding how hMSCs respond to different environments will facilitate 
the engineering of biomaterials with the appropriate properties for cell attachment and 




day of cell incubation. hMSC proliferation was observed with a WST-1 assay 1, 3 and 
7 days after cell seeding (132). 
5.3 Materials and Methods 
5.3.1 Chemicals 
Fmoc-protected amino acids, N-Hydroxybenzotriazole (HOBt) and O-
Benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU) were 
purchased from Aapptec and used as received. Rink amide MBHA resin was 
purchased from Chem Impex. Dimethylformamide (DMF) was purchased from 
Macron. Acetic anhydride and trifluoroacetic acid (TFA) were purchased from Alfa 
Aesar.   Piperidine, N,N-Diisopropylethylamine (DIEA), MeOH, triisopropylsilane 
(TIPS), 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt (TSP) and diethyl 
ether were purchased from Sigma-Aldrich.  WST-1 kit was purchased from Takara. 
Live/dead assay kit was purchased from Invitrogen. All components for hMSC basal 
growth media were also purchased from Invitrogen. hMSCs were purchased from 
Lonza. 
5.3.2 Oligopeptide Design and Synthesis 
Four oligopeptides were designed using the approach described in chapter 3, 
in which oppositely charged oligopeptide modules interact electrostatically, co-
assemble and form a hydrogel.  Detailed synthesis and purification procedures for 





) were made with alternating neutral (W and A) and positively 




either all L-amino acids or all D-amino acids. The two negative sequences (L  and 
D ) were made with alternating neutral (W and A) and negatively charged (E) amino 
acids.  The oligopeptide sequences of these positively and negatively charged 





):        acetyl-K-W-K-A-K-A-K-A-K-W-K-amide   
Negative modules (L
 
or D ):       acetyl-E-W-E-A-E-A-E-A-E-W-E-amide   
Since these oligopeptide solutions were used for cell culture purposes, they 
were sterile filtered directly prior to gelation.  The pH of each oligopeptide solution 
was 7.4. 
5.3.3 Hydrogel Preparation 
Our hydrogels are formed by mixing solutions of oppositely charged 
oligopeptide modules.  In each hydrogel, the total oligopeptide concentration was 5 
mM.  All gels were made 24 hours before cell seeding. In total, 9 gel types were made 
under sterile conditions at 25°C (see Appendix, Figure A27). 
To investigate chirality, neutral homochiral, heterochiral and racemic 
hydrogels were prepared.  The neutral homochiral (LL)
0
 gel was made by mixing 
equal volumes of 5 mM L
+
 with 5 mM L
-
.  The neutral homochiral (DD)
0
 gel was 
made by mixing equal volumes of 5 mM D
+
 with 5 mM D
-





 gels were made by 1:1 mixing of 5 mM L
+
 with 5 mM D
-
 and 1:1 
mixing of 5 mM D
+
 with 5 mM L
-
, respectively.  The neutral racemic hydrogel, 
(LLDD)
0












, each with a 1.25 mM final concentration in the 
hydrogel).  
To investigate charge-chirality interplay, charged homochiral gels were 
prepared by varying the positive to negative oligopeptide ratio in the hydrogel while 














, resulting in 1 mM of excess of positively charged oligopeptide in 




 gels were made by mixing equal 








, resulting in 1 mM of excess of 
negatively charged oligopeptide in the hydrogel.  
5.3.4 Nuclear Magnetic Resonance (NMR) Measurements 
Individual oligopeptide solutions were pre-equilibrated at room temperature 







 gels were loaded into NMR tubes by quickly mixing 




 solution together in a 1.5 mL plastic centrifuge tube 
and transferring the mixture to a 3-mm NMR tube using a long glass disposable 
pipette. Gels were allowed to mature for 24 hours at 25˚C and then both gels and 
solutions were contained in 3-mm NMR tubes (inner tubes).  Each 3-mm inner tube 
was placed one at a time in the same 5-mm NMR outer tube containing 100% D2O to 
provide the deuterium lock signal.  With this setup, solutions and gels did not come in 
contact with D2O. 
 NMR experiments were carried out on a Varian 400-MR spectrometer 




NMR spectrometer probe was preset to 25˚C. 
1
H spectra were used to examine the 
presence of free oligopeptide in each gel after 24 hours. Due to the very short 
transverse relaxation time (T2) of gelled oligopeptides, only free oligopeptides can be 
detected by NMR spectroscopy (133). To compare the signal intensities from 
different 1D 
1
H spectra, the same calibrated 90˚ pulse and the same receiver gain 
were used in all cases.  All samples contained an external TSP standard in the outer 
D2O tube in order to calibrate 
1
H peak height and chemical shift. The number of 
averages for each 
1
H spectrum was 16. 
5.3.5 Cell Culture 
hMSCs were cultured in high glucose Dulbecco’s modified eagle medium 
(DMEM) supplemented with 10% FBS, 1% penicillin/streptomycin (100 U/mL), 1% 
nonessential amino acids (0.1 mM), 2% L-glutamine (4 mM) and incubated at 37°C, 
5% CO2. The medium was changed every two days. The cells were detached from 
flasks with PBS containing 0.25% w/v Trypsin-EDTA, were centrifuged and then 
resuspended in DMEM for re-plating on various hydrogels and tissue culture 
polystyrene (TCPS) plates. 
5.3.6 Cell Attachment 
hMSCs (passage 5 or 6) were seeded onto the surfaces of the hydrogels in a 
96-well plate at a density of 1×10
5
 cells/mL in the culture medium and the cells were 
incubated for one day at 37˚C. To assess cell attachment one day after seeding, a 
live/dead assay was used. Cells were washed with PBS and incubated in PBS 




30 minutes. Cells were washed again and incubated in PBS containing 4',6-
diamidino-2-phenylindole (DAPI) for 10 minutes. hMSCs were then visualized by 
spinning disk microscope (SDM, Olympus IX81) at excitation wavelengths of 358 
nm, 488 nm and 532 nm. DAPI was used to locate and focus on the cells within the 
gel, in an effort to minimize photobleaching of calcein-AM and ethidium homodimer-
1. Cells cultured on a tissue culture polystyrene 96-well plate without hydrogel 
(TCPS) and the nine hydrogel types without cells were used as positive and negative 
controls respectively. Three wells were made per hydrogel type, six images were 
taken per well, and the assay was performed in triplicate, so a total of 54 images were 
taken per hydrogel type. Cells were counted using NIH ImageJ software (73). 
Relative attachment was calculated by normalizing the average number of 
experimental live cells per image to the average number of TCPS control live cells 
per image. 
 To study the effect of single oligopeptides on hMSC attachment, 50 μL of 2 
mM oligopeptide in PBS was added to each well. Then, 50 μL of media containing 
2×10
5
 cells/mL was added to each well, making the final total concentration of 
oligopeptide 1 mM. The cells were then incubated for one day at 37˚C. A live/dead 
assay was also used to assess cell attachment. Cells grown in normal media on TCPS 
and 1 mM oligopeptide on TCPS without cells were used as positive and negative 
controls respectively. 
5.3.7 Cell Proliferation 
hMSCs (passage 5 or 6) were seeded onto the surface of the hydrogels in a 96-
well plate at a density of 7×10
4




days. Cells cultured on a 96-well plate without hydrogel (TCPS) and hydrogel 
without cells were used as positive and negative controls respectively. At different 
time points (day 1, day 3 and day 7), the proliferation of viable cells was assessed by 
the WST-1 assay. This assay is based on the cleavage of the tetrazolium salt WST-1 
to formazan by cellular mitochondrial dehydrogenases present in viable cells.
20
 
Absorption by formazan at 450 nm was used to measure proliferation.  Absorbance 
from negative controls at 450 nm was subtracted from all experimental results. The 
proliferation results were then expressed as a percentage of the absorbance of the 
positive control.  
To study the effect of single oligopeptides on hMSC proliferation, 50 μL of 2 
mM oligopeptide in PBS was added to each well. Then, 50 μL of media containing 
2×10
5
 cells/mL was added to each well, making the final concentration of the 
oligopeptide 1 mM. Medium containing 1 mM oligopeptide was changed every two 
days. Cell proliferation was still assessed using the WST-1 assay. Cells grown in 
normal media on TCPS and 1 mM oligopeptide on TCPS without cells were used as 
positive and negative controls respectively. 
5.4 Results and Discussion 
5.4.1 Experimental Design 
To investigate how chirality and charge of hydrogels affect hMSC behavior, 




, were made; 
also made were two mirror-image negatively charged oligopeptide modules, L  and 




in PBS.  Note that although all oligopeptide modules are homochiral and charged, 
different combinations of oppositely charged oligopeptides result in hydrogels of 
different chirality (homochiral, heterochiral or racemic) and charge (positive, neutral 
or negative) statuses. This is the advantage afforded by the co-assembly approach to 
hydrogelation.     
To investigate the effect of hydrogel chirality on hMSC behavior, five neutral 
hydrogels, including homochiral, heterochiral and racemic types, were made.  The 




, were mirror images of each other.  So were the 




.  The racemic hydrogel, (LLDD)
0
, was its own 
mirror image.  
To investigate the interplay of charge and chirality on hMSC behavior, six 
homochiral gels of different charge statuses were made.  The six hydrogels were 








, and (LL)  
and (DD) .   
In total, 9 hydrogels of different chirality and charge statuses were assembled 
from 4 homochiral charged oligopeptides.  Figure 5.1 lists all 4 parent oligopeptides, 





Figure 5.1. Pictorial description of the 4 parent oligopeptides and 9 hydrogels. The 
dashed lines connect mirror images which all run through (LLDD)
0
, which is its own 
mirror image. Red hands represent positively charged oligopeptides and blue hands 
represent negatively charged oligopeptides. Circles represent parent oligopeptide 
solutions. Squares represent the hydrogels. The asterisk represents the center that all 
dashed mirror lines run through. 
5.4.2 Effect of Oligopeptide Chirality and Charge on hMSC Attachment and 
Proliferation 
It is important to separate the impact of a hydrogel from the impact of its 
constitutive oligopeptides.  For this purpose, the impact of the four parent 
oligopeptides on hMSC behavior was assessed.  The results are presented in Figure 
5.2.  All four oligopeptides had 5-10% lower cell attachment and 15-20% lower 
proliferation in comparison to the control (TCPS).  However, there is no statistically 
significant difference among the four oligopeptides (p > 0.01, Appendix Table A2).  




nine hydrogels is caused by differences in hydrogels, not differences in constitutive 
peptides. 
 
Figure 5.2. (A) Relative hMSC attachment to TCPS in the presence of single 
oligopeptides 1 day after cell seeding. (B) hMSC cell number percentage on TCPS in 
the presence of single oligopeptides at 1, 3 and 7 days after seeding. Bar order and 
colors in (B) correspond to the same order and colors in (A). Adjacent bars separated 
by dashed lines are a pair of mirror images. For (A), results were normalized to 
TCPS. For (B), results were normalized to TCPS day 7. For both graphs, errors are 
expressed as the standard error of the mean (SEM). 
 
5.4.3 Chirality Effects on hMSC Attachment and Proliferation 
Compared to TCPS, all five neutral gels had 70-80% lower hMSC attachment 
and 40-60% lower hMSC proliferation (Figure 5.3).  Considering these oligopeptides 
do not contain any known cell adhesion motif, this result is not unexpected.  Among 
the five neutral hydrogels, the homochiral (LL)
0
 gel had the highest hMSC attachment 
while the racemic (LLDD)
0







 gel, showed no statistically significant difference in cell 
attachment. 








































































Figure 5.3. (A) Relative hMSC attachment to neutral homochiral and heterochiral 
gels at 1 day after cell seeding. (B) hMSC cell number percentage on neutral 
homochiral and heterochiral gels at 1, 3 and 7 days after seeding. Bar order and colors 
in (B) correspond to the same order and colors in (A). Adjacent bars separated by 
dashed lines are a pair of mirror images. For (A), results were normalized to TCPS. 
For (B), results were normalized to TCPS day 7. For both graphs, errors are expressed 
as the standard error of the mean (SEM). 
 
Clear differences in hMSC appearance and survival can be seen in Figure 5.4. 
Here, cells on (LL)
0 
gels appear blurry. The cells are situated at different focal planes, 
which suggest that they have penetrated into the gel matrix.  None of the other gel 
images appear blurry, indicating that the cells stay on the surface of these gels.  It is 
interesting that such penetration is unique to the gel whose chirality matches the 
chirality of the proteins on the cell surface.  Such chirality matching is likely the 
reason that the (LL)
0
 gel has better cell attachment and proliferation than the other 
gels.  The question is whether chirality mismatch can be compensated by other 






































































Figure 5.4. Representative live/dead images for neutral gels and TCPS control at 1 
day after cell seeding. Live hMSCs are green and dead hMSCs are red. Cell size is 
much larger and image clarity is much cloudier for (LL)
0
 images when compared with 
(DD)
0
 and heterochiral images. These images indicate cell sinking into LL gels, but 
not into gels containing D-oligopeptide. 
 
After initial attachment, hMSC proliferation was assessed on days 1, 3 and 7.  
All five gels supported hMSC proliferation during the seven-day period.  However, 




, had the largest increase in proliferation.  






gels supported statistically the same amount of 




gels supported significantly less 




gels had the highest level of hMSC 
proliferation while (LLDD)
0 
supported the lowest amount of hMSC proliferation. This 




for hMSC proliferation than heterochiral oligopeptide gels, which in turn have higher 
potential than racemic oligopeptide gels for hMSC proliferation.  
Considering that (DD)
0
 has the “wrong” homochirality, it is not surprising that 
it does not support cell attachment and proliferation as well as (LL)
0
.  However, in 
spite of its initial much lower level of hMSC attachment and proliferation, hMSC 
proliferation on (DD)
0
 eventually almost catches up with hMSC proliferation on 
(LL)
0
.  Among the five gels, (DD)
0
 would be the most protease resistant.  (DD)
0
 also 
has the same mechanical and structural properties as (LL)
0
 (49).  Hence (DD)
0
 is the 
most promising replacement of (LL)
0
.  With this in mind, we decided to investigate 
whether charge could make up the chiral disadvantage of the D-homochiral gel in 
hMSC attachment and proliferation.     
5.4.4 Combined Charge and Chirality Effects on hMSC Attachment and Proliferation 
Charged homochiral hydrogels were made by mixing the positively and 
negatively charged modules with one module in excess.  Specifically, (LL)
+
 has 1 













 has 1 mM excess of D
-
.  Please note that the total oligopeptide 
concentration in charged gels is still 5 mM, the same as neutral gels.  It is important 
to verify that the excess oligopeptide is indeed incorporated into the hydrogel rather 










 gels to 
determine whether there was a significant difference in the amount of free 
oligopeptides after 24 hours of gelation. The 
1




compared (Figure 5.5). Peak heights of the three gels were comparable to each other.  
This result indicates that the excess oligopeptide in a charged gel was incorporated 
into the hydrogel matrix to the same extent as the neutral gel, with hardly any free 
oligopeptide left.  Hence any observed effects of the charged hydrogels on the hMSCs 
are indeed caused by charged hydrogels, not by charged free oligopeptides. 
 
Figure 5.5. 1D 
1




 gel and (LL)
-
 gel plotted on the 
same scale.  The figure is divided into two parts to exclude the unsuppressed portion 
of the H2O peak around 4.75 ppm. The left panel is the aromatic region and the right 
panel is the aliphatic region. Here, the peak heights for all three gels very similar and 
small, indicating a lack of free oligopeptide present in the gels after 24 hours. Peak 
heights were calibrated using the proton signal from TSP (9mM proton 
concentration). 
 
When homochiral gels of different charge statuses are compared (Figure 5.6), 
there is no statistically significant difference among the LL-gels in terms of hMSC 
attachment and proliferation.  The only exception is that (LL)
0
 had statistically 
significant higher cell attachment than (LL)
+







, the following trend of hMSC attachment and proliferation is 
observed: 
 
                                              (DD)   >  (DD)
0
  >  (DD)
+








The above order was statistically significant for both attachment and proliferation on 
day 1 but became less significant for proliferation on days 3 and 7 (Appendix Table 
A2).  Nonetheless, the trend is very clear (Figure 5.6B).   
 
Figure 5.6. (A) Relative hMSC attachment to charged and neutral homochiral gels at 
1 day after cell seeding. (B) hMSC cell number percentage on charged and neutral 
homochiral gels at 1, 3 and 7 days after seeding. Bar order and colors in (B) 
correspond to the same order and colors in (A). Adjacent bars separated by dashed 
lines are a pair of mirror images. For (A), results were normalized to TCPS. For (B), 
results were normalized to TCPS day 7. For both graphs, errors are expressed as the 
standard error of the mean (SEM). 
 
In Figure 5.7, the difference between the number of live cells on (DD)  vs. (DD)
+
 is 
also apparent. Figure 5.8 compares L-homochiral with D-homochiral gels of different 
charge statuses.   Negative charges reduce the difference between L- and D- 
homochiral gels while positive charges amplify such difference.  On day 7, there is no 
difference at all between (LL)  and (DD)  in cell proliferation.  Hence, in terms of 
hMSC attachment and proliferation, the chirality mismatch between matrix and cells 
can be compensated to various extents by negative charges.  However, negative 
































































evident that images of cells on L-gels are blurry because they are situated on different 
focal planes, while images of cells on D-gels, regardless of charge status, remain 
clear.  
 
Figure 5.7. Representative live/dead images for charged and neutral homochiral gels 
at 1 day after cell seeding. Live hMSCs are green and dead hMSCs are red. Cell size 
is much larger and image clarity is much cloudier for LL images when compared with 
DD images. These images indicate cell penetrating into LL gels, but not into DD gels. 
 
     The reason why negative charges enhance the biocompatibility of the D-
homochiral gel awaits further study.  However, it is clear that such interplay between 
charge and chirality is unique to the D-homochiral gel since the L-homochiral gel 
shows no such trend at all (Figure 5.6 and appendix Table A2). Also clear is that this 
effect is not caused by negatively charged free peptides because hardly any is left in 




























Figure 5.8. Calculated differences (LL – DD) in cell behavior on positive, neutral and 
negative gel pairs. In the figure legend, N1 is cell number day 1, N3 is cell number 
day 3, N7 is cell number day 7 and A1 is attachment day 1. Differences between 
positive pairs are larger than differences between negative pairs in both experiments 
and at all time points. 
 
5.5 Conclusion 
This work shows that, among oligopeptide hydrogels of various chiral 
compositions, the L-homochiral gel is the most biocompatible, leading to highest 
hMSC attachment and proliferation, while the racemic gel is the least biocompatible, 
leading to lowest hMSC attachment and proliferation.  Most importantly, the 
disadvantage of the D-homochiral gel can be compensated by negative charges.  This 
result points to the possibility of using charge and other factors to engineer 
biomaterials whose chirality is distinct from that of natural biomaterials but whose 
performance is close to that of natural biomaterials. Aside from practical applications, 
such materials offer new tools and opportunities to investigate biohomochirality, an 






Chapter 6: Conclusions 
In this dissertation work, combinations of different types of biopolymers were 
investigated in order to create materials with the desired structural and mechanical 
properties in an effort to mimic natural vertebrate extracellular matrix. The 
constitutive biopolymers investigated include natural polysaccharides and engineered 
oligopeptides. 
Creating the strongest materials possible requires an understanding of how 
individual network components and various conditions affect bulk material 
properties. In chapter 2, we examined how the addition of chondroitin affected the 
properties of chitosan-alginate networks. Samples containing chondroitin were stiffer 
and had greater tensile strengths than samples without chondroitin. However, the 
effectiveness of chondroitin addition was dependent on the order in which it was 
added. Effects of total polysaccharide concentration were also studied. Higher 
concentrations were associated with greater mechanical strengths. Structural analysis 
of the networks complemented the findings in this chapter, illustrating that 
chondroitin addition increased fiber thickness while Ca
2+
 addition caused fiber 
contraction thereby increasing fiber stiffness. Together, the two modifiers improved 
network density, resulting in greater stiffness and tensile strength.  
In chapter 3, we prepared composite hydrogels in which the fibrous peptide 
networks were combined with the fibers assembled from long, charged 
polysaccharide structures. In this way, our materials would mimic the chemical 
and/or structural composition of extracellular matrix.  The pure polysaccharide 




resistance to deformation.  Incorporation of the polysaccharides into the oligopeptide 
hydrogel also resulted in materials (CAP and CADP) with very high resistance to 
deformation (strain values from 20 % to 100 %), far less brittle compared to the pure 
peptide hydrogel P.  However, the propensity of the oligopeptides to form complexes 
with the polysaccharides may be responsible for the significant loss of stiffness of the 
composite material as compared to the pure peptide hydrogel. Structural analysis 
illustrated the aforementioned interaction between the oligopeptides and sugars. 
These results suggest a novel approach for creating highly deformation-resistant 
biomaterials.  
In chapter 4, we studied the mechanical and structural properties of L/L and 
D/D oligopeptide hydrogels doped with four unique D-saccharide types. In all cases, 
at varying concentrations, L/L gels gelled faster and/or were stiffer than D/D gels in 
the presence of all saccharide types. This result suggests stronger interactions 
between L-oligopeptides and D-saccharides, regardless of saccharide size, shape or 
charge. Structural analysis corroborated these findings using a combination of 
techniques to examine the gels at the level of the fiber and the level of the network. 
This approach can provide insight on using chirality as another tool for tuning the 
properties of biopolymer-based biomaterials. In addition, it may give insight from a 
mechanical standpoint for why proteins and saccharides have opposite chirality in 
nature. 
In chapter 5, the effects of chirality and charge on human mesenchymal stem 
cell (hMSC) behavior were studied using hydrogels assembled from oppositely 




hMSC attachment and proliferation in D-oligopeptide gels but had little effect on 
their interactions with L-oligopeptide gels.  This means that the disadvantage of the 
D-homochiral gel can be compensated by negative charges.  From this result, we see 
the possibility of using charge and other factors to engineer oligopeptide-based 
biomaterials whose chirality is distinct from that of natural biomaterials but whose 
performance is close to that of natural biomaterials. These biomaterials also offer new 
tools and opportunities to investigate biohomochirality, an important and unresolved 
question in biology. 
 Taken together, this dissertation work provides a better understanding 
about how biopolymer interactions affect mechanical and structural properties of 
biomaterials, and how those properties can affect stem cell behavior. Further studies 
will continue to characterize and define the biological potential of these new materials 






Table A1. Young’s modulus obtained by compression of dry type 5C networks. 
Ultimate tensile strength obtained by applying tension to dry type 5C networks. Test 
results for 5 type 5C networks, their averages and standard deviations. Separate 
samples were used for compression and tensile testing. 
Test Number Elastic modulus (MPa) Ultimate tensile strength (kPa) 
1 4.09 74.96 
2 4.21 77.12 
3 5.14 67.61 
4 4.75 69.27 
5 3.88 66.82 
Average 4.41 71.16 
Stdev 0.52 4.61 
 
 
Figure A1. Positively charged chitosan negatively charged alginate and negatively 






Figure A2. Analysis of SANS data for alginate. (a) Debye-Bueche estimation for 
correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche analysis. (c) Mass fractal 
estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. (e) Surface fractal 
estimation. (f) I(Q)*Q
4











Figure A3. Analysis of SANS data for chitosan. (a) Debye-Bueche estimation for 
correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche analysis. (c) Mass fractal 
estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. (e) Surface fractal 
estimation. (f) I(Q)*Q
4












Figure A4. Analysis of SANS data for chitosan+alginate. (a) Debye-Bueche 
estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche analysis. (c) 
Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. (e) Surface 
fractal estimation. (f) I(Q)*Q
4












Figure A5. Analysis of SANS data for chitosan+alginate+chondroitin. (a) Debye-
Bueche estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche 
analysis. (c) Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. 
(e) Surface fractal estimation. (f) I(Q)*Q
4













Figure A6. Analysis of SANS data for chitosan+alginate+calcium. (a) Debye-Bueche 
estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche analysis. (c) 
Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. (e) Surface 
fractal estimation. (f) I(Q)*Q
4



































1581.6 1642.01685.2 1754.8 1807.6 1882.5
























l-KWK-1-44-2.d: +MS  
Figure A7. Electrospray Ionization mass spectrometry (ESI-MS) was performed with 
a Bruker. ESI-MS experiments were performed by diluting each peptide solution with 
a 50:50 mix of ethanol and water. For EWE, detection was in negative mode. For 




Calculated Mass:  1413 
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+
 
  707.5 [1/2*M+H]
+
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Figure A8. Analytical reversed-phase HPLC chromatogram of peptides acquired with 
HP1100 chromatograph system (Agilent Technologies). Column: Zorbax 300SB-C18 
(4.6 × 250 mm i.d.). Elution profiles were monitored at 280nm. Eluents for EWE: 
solvent A: 20 mM NH4HCO3 in water, pH 7.0; solvent B: 20 mM NH4HCO3 in water 
(40%) + methanol (60%) mixture, pH 7.0. Eluents for KWK: solvent A: 0.1% 
trifluoroacetic acid (TFA) in water, pH 2.0; solvent B: 0.1% TFA in methanol, pH 
2.0. Chromatograph run conditions for all the peptides: flow rate: 1ml/min; gradient: 










Figure A9. Analysis of SANS data for Chitosan+Alginate. (a) Debye-Bueche 
estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche analysis. (c) 
Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. Error bars 







Figure A10. Analysis of SANS data for Chitosan+Alginate+Chondroitin. (a) Debye-
Bueche estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche 
analysis. (c) Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. 










Figure A11. Analysis of SANS data for Chitosan+Alginate+Peptides. (a) Debye-
Bueche estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-Bueche 
analysis. (c) Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal estimation. 










Figure A12. Analysis of SANS data for Chitosan+Alginate+Chondroitin+Peptides. 
(a) Debye-Bueche estimation for correlation length. (b) I(Q)*Q
4
 vs. Q fit for Debye-
Bueche analysis. (c) Mass fractal estimation. (d) I(Q)*Q
4
 vs. Q fit for mass fractal 










Sealed Cell C 25 4 
Manual control  Number of measurements 50000   Measurement interval  1.800E+2  s
Frequency table  Frequency  1.592E-1  Hz  Delay time  5.000E+0  s  Integration periods 2   
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Figu e A1 . me-sweep measurements of viscoelastic properties of 






Sealed Cell C 25 4 
Manual control  Number of measurements 50000   Measurement interval  1.800E+2  s
Frequency table  Frequency  1.592E-1  Hz  Delay time  5.000E+0  s  Integration periods 2   
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Figure A14. Time-sweep measurements of viscoelastic properties of 
Chitosan+Alginate+Chondroitin performed after frequency-sweep confirming the 






Sealed Cell C 25 4 
Manual control  Number of measurements 50000   Measurement interval  1.800E+2  s
Frequency table  Frequency  1.592E-1  Hz  Delay time  5.000E+0  s  Integration periods 2   
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Figure A15. Tim -swe p measure e ts of vi coelastic properties of peptide 







Sealed Cell C 25 4 
Manual control  Number of measurements 50000   Measurement interval  1.800E+2  s
Frequency table  Frequency  1.592E-1  Hz  Delay time  5.000E+0  s  Integration periods 2   
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Figure A16. Time-sweep m asurements of viscoelastic properties of mixed peptide 
Chitosan+Alginate hydrogel performed after frequency-sweep confirming the 






Sealed Cell C 25 4 
Manual control  Number of measurements 50000   Measurement interval  1.800E+2  s
Frequency table  Frequency  1.592E-1  Hz  Delay time  5.000E+0  s  Integration periods 2   
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Figure A17. Time-sweep m asurements of viscoelastic properties of mixed peptide 
Chitosan+Alginate+Chondroitin hydrogel performed after frequency-sweep 





(A)      (B) 
  
(C)      (D) 
Figure A18. Histograms (A&C) and representative slices (B&D) from CAD 
(chitosan+alginate+chondroitin) and CADP (chitosan+alginate+chondroitin and 
peptide hydrogel from KWK and EWE) samples. 
   
 To obtain the above slices we have processed the SANS data of the CAD and 
CADP networks (Figure S12) using SAXSMorph program (Ingham, B.; Li, H.; 
Allen, E. L.; Toney, M. F. J. Appl. Cryst. 2011, 44, 221–224) and areas within each 
slice were found using NIH ImageJ routine (Abramoff, M. D.; Magelhaes, P. J.; Ram, 
S. J. Biophotonics International 2004, 11, 36–42). The areas found within each slice 
were combined into histograms (A&C) which gave notably different distributions. It 
is apparent in both the qualitative slices and the corresponding quantitative 
histograms that the addition of peptides into the system decreases the size of the 
fibers and the aggregations. The histogram for CAD shows multiple areas larger than 
70,000 Å
2
 whereas the histogram for CADP does not have any areas larger than 
70,000 Å
2
. From the qualitative slices, a difference in the size of areas in CAD and 
CADP is also visually noticeable. These findings are consistent with the shape 
analysis which shows that peptide addition greatly influences the resulting material, 























Figure A19. Analytical reversed-phase HPLC chromatogram of L
+
 acquired with 
HP1100 chromatograph system (Agilent Technologies). Column: Zorbax 300SB-C18 
(4.6 × 250 mm i.d.). Elution profiles were monitored at 280nm. Eluents: solvent A: 
0.1% trifluoroacetic acid (TFA) in water, pH 2.0; solvent B: 0.1% TFA in methanol, 
pH 2.0. Chromatograph run conditions for all the peptides: flow rate: 1ml/min; 

















Figure A20. Analytical reversed-phase HPLC chromatogram of L
-
 acquired with 
HP1100 chromatograph system (Agilent Technologies). Column: Zorbax 300SB-C18 
(4.6 × 250 mm i.d.). Elution profiles were monitored at 280nm. Eluents: solvent A: 
20 mM NH4HCO3 in water, pH 7.0; solvent B: 20 mM NH4HCO3 in water (40%) + 
methanol (60%) mixture, pH 7.0. Chromatograph run conditions for all the peptides: 


















Figure A21. Analytical reversed-phase HPLC chromatogram of D
+
 acquired with 
HP1100 chromatograph system (Agilent Technologies). Column: Zorbax 300SB-C18 
(4.6 × 250 mm i.d.). Elution profiles were monitored at 280nm. Eluents: solvent A: 
0.1% trifluoroacetic acid (TFA) in water, pH 2.0; solvent B: 0.1% TFA in methanol, 
pH 2.0. Chromatograph run conditions for all the peptides: flow rate: 1ml/min; 
















Figure A22. Analytical reversed-phase HPLC chromatogram of D
-
 acquired with 
HP1100 chromatograph system (Agilent Technologies). Column: Zorbax 300SB-C18 
(4.6 × 250 mm i.d.). Elution profiles were monitored at 280nm. Eluents: solvent A: 
20 mM NH4HCO3 in water, pH 7.0; solvent B: 20 mM NH4HCO3 in water (40%) + 
methanol (60%) mixture, pH 7.0. Chromatograph run conditions for all the peptides: 










 Mass spectrum acquired with an Amazon X Ion Trap Mass 
Spectrometer (Bruker) in positive ion mode. Flow rate of 3 μL/min, 10 psi nebulizer 








 mass spectrum acquired with an Amazon X Ion Trap Mass 
Spectrometer (Bruker) in negative ion mode. Flow rate of 3 μL/min, 10 psi nebulizer 







[M] = 1417 
[M]/2 = 708.5 
[M]/3 = 472.3 
[M]/4 = 
354.25 
[M+H]+ = 1414 
[M/2+H]+ = 707.5 










 mass spectrum acquired with an Amazon X Ion Trap Mass 
Spectrometer (Bruker) in positive ion mode. Flow rate of 3 μL/min, 10 psi nebulizer 







 mass spectrum acquired with an Amazon X Ion Trap Mass 
Spectrometer (Bruker) in negative ion mode. Flow rate of 3 μL/min, 10 psi nebulizer 
pressure, 4 L/min dry gas flow and 250˚C gas temperature. 
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Figure A27.  Pictorial description of how each gel was made using different amounts 
of four parent oligopeptides. The final oligopeptide concentration for all gels was 5 
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Table A2. Results from a series of paired t-tests to determine significant differences 
in cell behavior on different hydrogel types. Table (A) shows attachment and table 
(B) shows proliferation. For acceptance, p < 0.01. 
 
A. Attachment (n = 54) 
 Hypothesis p value Result 
Single Peptides 
L- > L+ 0.4 rejected 
L+ > D+ 0.2 rejected 
L- > D- 0.2 rejected 
D- > D+ 0.2 rejected 
D- > L+ 0.4 rejected 
L- > D+ 0.05 rejected 
Neutral Gels 
(LL)0 > (LD)0 5.0E-05 accepted 
(LL)0 > (DL)0 0.0001 accepted 
(DL)0 > (LD)0 0.1 rejected 
(LD)0 > (DD)0 0.2 rejected 
(DL)0 > (DD)0 0.04 rejected 
(LL)0 > (DD)0 1.0E-06 accepted 
(DD)0 > 
(LLDD)0 0.011 rejected 
(LD)0 > (LLDD)0 0.001 accepted 
(DL)0 > (LLDD)0 8.00E-04 accepted 
Charged Gels 
(DD)0 > (DD)+ 0.004 accepted 
(DD)- > (DD)0 0.009 accepted 
(LL)+ > (DD)+ 1.0E-06 accepted 
(LL)- > (DD)- 0.004 accepted 
(LL)0 > (LL)+ 0.001 accepted 
(LL)0 > (LL)- 0.1 rejected 
(LL)- > (LL)+ 0.04 rejected 
 
 
B. Proliferation (n = 9) 
  Hypothesis Day p value Result 
Single Peptides 
L- > L+ 1 0.2 rejected 




L- > D- 1 0.1 rejected 
D- > D+ 1 0.06 rejected 
D- > L+ 1 0.2 rejected 
L- > D+ 1 0.02 rejected 
L- > L+ 3 0.2 rejected 
L+ > D+ 3 0.5 rejected 
L- > D- 3 0.5 rejected 
D- > D+ 3 0.3 rejected 
D- > L+ 3 0.3 rejected 
L- > D+ 3 0.2 rejected 
L- > L+ 7 0.4 rejected 
L+ > D+ 7 0.4 rejected 
L- > D- 7 0.4 rejected 
D- > D+ 7 0.4 rejected 
D- > L+ 7 0.5 rejected 
L- > D+ 7 0.2 rejected 
Neutral Gels 
(LL)0 > (LD)0 1 0.3 rejected 
(LL)0 > (DL)0 1 0.3 rejected 
(DL)0 > (LD)0 1 0.3 rejected 
(LD)0 > (DD)0 1 3.0E-05 accepted  
(DL)0 > (DD)0 1 3.0E-05 accepted  
(LL)0 > (DD)0 1 7.0E-04 accepted  
(LL)0 > (LLDD)0 1 0.004 accepted  
(LD)0 > (LLDD)0 1 7.0E-04 accepted  
(DL)0 > (LLDD)0 1 0.002 accepted  
(LLDD)0 > (DD)0 1 0.2 rejected 
(LL)0 > (LD)0 3 0.2 rejected 
(LL)0 > (DL)0 3 0.2 rejected 
(DL)0 > (LD)0 3 0.3 rejected 
(LD)0 > (DD)0 3 0.4 rejected 
(DL)0 > (DD)0 3 0.3 rejected 
(LL)0 > (DD)0 3 0.03 rejected 
(LL)0 > (LLDD)0 3 2.0E-04 accepted  
(LD)0 > (LLDD)0 3 4.0E-04 accepted  
(DL)0 > (LLDD)0 3 0.002 accepted  




(LL)0 > (LD)0 7 0.003 accepted  
(LL)0 > (DL)0 7 6.0E-04 accepted  
(DL)0 > (LD)0 7 0.3 rejected 
(DD)0 > (LD)0 7 0.1 rejected 
(DD)0 > (DL)0 7 0.09 rejected 
(LL)0 > (DD)0 7 0.2 rejected 
(LD)0 > (LLDD)0 7 3.0E-05 accepted  
(DL)0 > (LLDD)0 7 3.0E-05 accepted  
(DD)0 > (LLDD)0 7 5.0E-05 accepted  
Charged Gels 
(DD)0 > (DD)+ 1 0.004 accepted  
(DD)- > (DD)0 1 5.0E-04 accepted  
(DD)- > (DD)+ 1 0.002 accepted  
(LL)+ > (DD)+ 1 5.0E-06 accepted  
(LL)- > (DD)- 1 0.0004 accepted  
(LL)0 > (LL)+ 1 0.014 rejected 
(LL)- > (LL)0 1 0.09 rejected 
(LL)- > (LL)+ 1 0.03 rejected 
(DD)0 > (DD)+ 3 0.014 rejected 
(DD)- > (DD)0 3 0.1 rejected 
(DD)- > (DD)+ 3 0.004 accepted  
(LL)+ > (DD)+ 3 0.005 accepted  
(LL)- > (DD)- 3 0.09 rejected 
(LL)0 > (LL)+ 3 0.4 rejected 
(LL)- > (LL)0 3 0.4 rejected 
(LL)- > (LL)+ 3 0.5 rejected 
(DD)0 > (DD)+ 7 0.1 rejected 
(DD)- > (DD)0 7 0.2 rejected 
(DD)- > (DD)+ 7 0.002 accepted  
(LL)+ > (DD)+ 7 0.006 accepted  
(LL)- > (DD)- 7 0.5 rejected 
(LL)0 > (LL)+ 7 0.2 rejected 
(LL)- > (LL)0 7 0.5 rejected 
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